
<html lang="en"     class="pb-page"  data-request-id="c838ee4b-5987-4cb7-a23d-206b28468a1c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00280;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-15;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)" /></meta><meta name="dc.Creator" content="Antonio  Ugolini" /></meta><meta name="dc.Creator" content="Mireille  Kenigsberg" /></meta><meta name="dc.Creator" content="Alexey  Rak" /></meta><meta name="dc.Creator" content="Francois  Vallée" /></meta><meta name="dc.Creator" content="Jacques  Houtmann" /></meta><meta name="dc.Creator" content="Maryse  Lowinski" /></meta><meta name="dc.Creator" content="Cécile  Capdevila" /></meta><meta name="dc.Creator" content="Jean  Khider" /></meta><meta name="dc.Creator" content="Eva  Albert" /></meta><meta name="dc.Creator" content="Nathalie  Martinet" /></meta><meta name="dc.Creator" content="Conception  Nemecek" /></meta><meta name="dc.Creator" content="Sandrine  Grapinet" /></meta><meta name="dc.Creator" content="Eric  Bacqué" /></meta><meta name="dc.Creator" content="Manfred  Roesner" /></meta><meta name="dc.Creator" content="Christine  Delaisi" /></meta><meta name="dc.Creator" content="Loreley  Calvet" /></meta><meta name="dc.Creator" content="Fabrice  Bonche" /></meta><meta name="dc.Creator" content="Dorothée  Semiond" /></meta><meta name="dc.Creator" content="Coumaran  Egile" /></meta><meta name="dc.Creator" content="Hélène  Goulaouic" /></meta><meta name="dc.Creator" content="Laurent  Schio" /></meta><meta name="dc.Description" content="The HGF/MET pathway is frequently activated in a variety of cancer types. Several selective small molecule inhibitors of the MET kinase are currently in clinical evaluation, in particular for NSCLC..." /></meta><meta name="Description" content="The HGF/MET pathway is frequently activated in a variety of cancer types. Several selective small molecule inhibitors of the MET kinase are currently in clinical evaluation, in particular for NSCLC..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 13, 2016" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00280" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00280" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00280" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00280" /></link>
        
    
    

<title>Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00280" /></meta><meta property="og:title" content="Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0012.jpeg" /></meta><meta property="og:description" content="The HGF/MET pathway is frequently activated in a variety of cancer types. Several selective small molecule inhibitors of the MET kinase are currently in clinical evaluation, in particular for NSCLC, liver, and gastric cancer patients. We report herein the discovery of a series of triazolopyridazines that are selective inhibitors of wild-type (WT) MET kinase and several clinically relevant mutants. We provide insight into their mode of binding and report unprecedented crystal structures of the Y1230H variant. A multiparametric chemical optimization approach allowed the identification of compound 12 (SAR125844) as a development candidate. In this chemical series, absence of CYP3A4 inhibition was obtained at the expense of satisfactory oral absorption. Compound 12, a promising parenteral agent for the treatment of MET-dependent cancers, promoted sustained target engagement at tolerated doses in a human xenograft tumor model. Preclinical pharmacokinetics conducted in several species were predictive for the observed pharmacokinetic behavior of 12 in cancer patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00280"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00280">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00280&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00280&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00280&amp;href=/doi/10.1021/acs.jmedchem.6b00280" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 7066-7074</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01813" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.5b02038" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-<i>b</i>]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Ugolini">Antonio Ugolini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mireille++Kenigsberg">Mireille Kenigsberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexey++Rak">Alexey Rak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francois++Vall%C3%A9e">Francois Vallée</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacques++Houtmann">Jacques Houtmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maryse++Lowinski">Maryse Lowinski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9cile++Capdevila">Cécile Capdevila</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean++Khider">Jean Khider</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Albert">Eva Albert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathalie++Martinet">Nathalie Martinet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Conception++Nemecek">Conception Nemecek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandrine++Grapinet">Sandrine Grapinet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Bacqu%C3%A9">Eric Bacqué</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manfred++Roesner">Manfred Roesner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Delaisi">Christine Delaisi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Loreley++Calvet">Loreley Calvet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice++Bonche">Fabrice Bonche</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Doroth%C3%A9e++Semiond">Dorothée Semiond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Coumaran++Egile">Coumaran Egile</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H%C3%A9l%C3%A8ne++Goulaouic">Hélène Goulaouic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Schio">Laurent Schio</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Medicinal Chemistry, <sup>‡</sup>Oncology Drug Discovery, <sup>§</sup>Structure Design & Informatics, and <sup>∥</sup>Protein Science & Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">⊥</span> <span class="aff-text">Disposition, Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Sanofi-Aventis Germany GmbH, Industriepark Hoechst, 65926 Frankfurt am Main, Germany</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#137f726661767d673d60707b7a7c5360727d7c757a3d707c7e"><span class="__cf_email__" data-cfemail="f995988c8b9c978dd78a9a919096b98a9897969f90d79a9694">[email protected]</span></a>. Phone: +33(0)1 58 93 88 14.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00280&amp;href=/doi/10.1021%2Facs.jmedchem.6b00280" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 7066–7074</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 29, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 February 2016</li><li><span class="item_label"><b>Published</b> online</span>13 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00280" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00280</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7066%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAntonio%2BUgolini%252C%2BMireille%2BKenigsberg%252C%2BAlexey%2BRak%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D15%26contentID%3Dacs.jmedchem.6b00280%26title%3DDiscovery%2Band%2BPharmacokinetic%2Band%2BPharmacological%2BProperties%2Bof%2Bthe%2BPotent%2Band%2BSelective%2BMET%2BKinase%2BInhibitor%2B1-%257B6-%255B6-%25284-Fluorophenyl%2529-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazin-3-ylsulfanyl%255Dbenzothiazol-2-yl%257D-3-%25282-morpholin-4-ylethyl%2529urea%2B%2528SAR125844%2529%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7074%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00280"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4543</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00280" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Ugolini&quot;},{&quot;first_name&quot;:&quot;Mireille&quot;,&quot;last_name&quot;:&quot;Kenigsberg&quot;},{&quot;first_name&quot;:&quot;Alexey&quot;,&quot;last_name&quot;:&quot;Rak&quot;},{&quot;first_name&quot;:&quot;Francois&quot;,&quot;last_name&quot;:&quot;Vallée&quot;},{&quot;first_name&quot;:&quot;Jacques&quot;,&quot;last_name&quot;:&quot;Houtmann&quot;},{&quot;first_name&quot;:&quot;Maryse&quot;,&quot;last_name&quot;:&quot;Lowinski&quot;},{&quot;first_name&quot;:&quot;Cécile&quot;,&quot;last_name&quot;:&quot;Capdevila&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;Khider&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Albert&quot;},{&quot;first_name&quot;:&quot;Nathalie&quot;,&quot;last_name&quot;:&quot;Martinet&quot;},{&quot;first_name&quot;:&quot;Conception&quot;,&quot;last_name&quot;:&quot;Nemecek&quot;},{&quot;first_name&quot;:&quot;Sandrine&quot;,&quot;last_name&quot;:&quot;Grapinet&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Bacqué&quot;},{&quot;first_name&quot;:&quot;Manfred&quot;,&quot;last_name&quot;:&quot;Roesner&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Delaisi&quot;},{&quot;first_name&quot;:&quot;Loreley&quot;,&quot;last_name&quot;:&quot;Calvet&quot;},{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;Bonche&quot;},{&quot;first_name&quot;:&quot;Dorothée&quot;,&quot;last_name&quot;:&quot;Semiond&quot;},{&quot;first_name&quot;:&quot;Coumaran&quot;,&quot;last_name&quot;:&quot;Egile&quot;},{&quot;first_name&quot;:&quot;Hélène&quot;,&quot;last_name&quot;:&quot;Goulaouic&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Schio&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7066-7074&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00280&quot;},&quot;abstract&quot;:&quot;The HGF/MET pathway is frequently activated in a variety of cancer types. Several selective small molecule inhibitors of the MET kinase are currently in clinical evaluation, in particular for NSCLC, liver, and gastric cancer patients. We report herein the discovery of a series of triazolopyridazines that are selective inhibitors of wild-type (WT) MET kinase and several clinically relevant mutants. We provide insight into their mode of binding and report unprecedented crystal structures of the Y1230H variant. A multiparametric chemical optimization approach allowed the identification of compound 12 (SAR125844) as a development candidate. In this chemical series, absence of CYP3A4 inhibition was obtained at the expense of satisfactory oral absorption. Compound 12, a promising parenteral agent for the treatment of MET-dependent cancers, promoted sustained target engagement at tolerated doses in a human xenograft tumor model. Preclinical pharmacokinetics conducted in several species were predictive for the observ&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00280&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00280" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00280&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00280" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00280&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00280" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00280&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00280&amp;href=/doi/10.1021/acs.jmedchem.6b00280" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00280" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00280" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00280%26sid%3Dliteratum%253Aachs%26pmid%3D27355974%26genre%3Darticle%26aulast%3DUgolini%26date%3D2016%26atitle%3DDiscovery%2Band%2BPharmacokinetic%2Band%2BPharmacological%2BProperties%2Bof%2Bthe%2BPotent%2Band%2BSelective%2BMET%2BKinase%2BInhibitor%2B1-%257B6-%255B6-%25284-Fluorophenyl%2529-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazin-3-ylsulfanyl%255Dbenzothiazol-2-yl%257D-3-%25282-morpholin-4-ylethyl%2529urea%2B%2528SAR125844%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D15%26spage%3D7066%26epage%3D7074%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/jmcmar.2016.59.issue-15/20160811-01/jmcmar.2016.59.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The HGF/MET pathway is frequently activated in a variety of cancer types. Several selective small molecule inhibitors of the MET kinase are currently in clinical evaluation, in particular for NSCLC, liver, and gastric cancer patients. We report herein the discovery of a series of triazolopyridazines that are selective inhibitors of wild-type (WT) MET kinase and several clinically relevant mutants. We provide insight into their mode of binding and report unprecedented crystal structures of the Y1230H variant. A multiparametric chemical optimization approach allowed the identification of compound <b>12</b> (SAR125844) as a development candidate. In this chemical series, absence of CYP3A4 inhibition was obtained at the expense of satisfactory oral absorption. Compound <b>12</b>, a promising parenteral agent for the treatment of MET-dependent cancers, promoted sustained target engagement at tolerated doses in a human xenograft tumor model. Preclinical pharmacokinetics conducted in several species were predictive for the observed pharmacokinetic behavior of <b>12</b> in cancer patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><p class="first">The MET receptor tyrosine kinase is activated by binding of its ligand, hepatocyte growth factor (HGF), resulting in receptor dimerization, autophosphorylation of Tyr1234/1235, and activation of the kinase domain and of the downstream multiple signaling pathways, including RAS/MAPK and PI3K/AKT, which in turn promote cell proliferation, survival, motility, invasion, angiogenesis, and morphogenesis.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The HGF/MET pathway plays an essential physiological role during embryogenesis<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and a more restricted role in tissue regeneration and damage repair in healthy adults.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Dysregulation of MET has been reported in several tumor types, either in the form of overexpression of the MET receptor or as mutations<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> and amplification<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> of the <i>MET</i> gene. Importantly, <i>MET</i> gene amplification was reported as an acquired resistance mechanism to EGFR tyrosine kinase inhibitor therapies in 10–20% of non-small-cell lung cancer (NSCLC) patients<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> and to anti-EGFR monoclonal antibody treatment in colorectal cancer (CRC) patients.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> More recently, HGF expression in the tumor stroma was reported as a resistance mechanism to BRAF inhibitors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p><p>Several orally bioavailable MET tyrosine kinase inhibitors, including capmatinib (INC280),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> tepotinib (EMD1214063),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> savolitinib (Volitinib/AZD6094/HMPL-504),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<i>R</i>)-6-(1-(8-fluoro-6-(1-methyl-1<i>H</i>-pyrazol-4-yl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6<i>H</i>)-one (AMG-337)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> as well as the MET/ALK/ROS inhibitor crizotinib,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> are in phase II clinical trials in papillary renal cell carcinoma, NSCLC, and gastroesophageal and hepatocellular cancer.</p><p>We report here the discovery, pharmacological characterization, preclinical and clinical pharmacokinetics of 1-{6-[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-<i>b</i>]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea, compound <b>12</b> (SAR125844), a potent intravenously active and highly selective MET kinase inhibitor, comparable to the aforementioned MET specific clinical candidates as assessed through biochemical and cellular profiling.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a></p><p>The original hit identification approach was based on a medium-throughput screening of an in-house biased kinase inhibitor library tested in a biochemical assay using nonphosphorylated MET kinase domain in order to identify all classes (DFG in (Asp-Phe-Gly), DFG out, α-helix out, etc.) of potential inhibitors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Subsequent biochemical assays were performed with phosphorylated MET kinase domain during the optimization phase.</p><p>A set of benzimidazole sulfonate derivatives with nanomolar MET inhibition was identified. In particular, the initial hit <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) exhibited an IC<sub>50</sub> of 5 nM against MET kinase but also displayed a strong undesirable affinity for cyclin dependent kinase CDK9 (IC<sub>50</sub> = 6 nM), an isoform involved in gene transcription processes. Modification of the sulfonylaryl moiety with more bulky substituents (e.g., chlorine vs fluorine atoms in analog <b>2</b>) was well tolerated in the MET protein (<b>2</b>, MET IC<sub>50</sub> = 23 nM) and resulted in prohibitive steric clashes and reduced binding to CDK9 (<b>2</b>, IC<sub>50</sub> = 1200 nM). However, compound <b>2</b> also displayed potent tubulin affinity (IC<sub>50</sub> = 2.7 μM, and microtubule poisons are active in the 0.5–3 μM substoichiometric concentration range in a microtubule assembly assay performed with 6–8 μM tubulin) leading to off-target cytotoxicity in non-MET-dependent tumor cell lines.</p><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit and lead finding steps.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Revisiting the internal compound collection retrieved a set of about 2000 benzimidazole derivatives from which a potent singleton originating from a former anthelmintic program was identified by testing on the phosphorylated MET kinase domain. Triazolopyridazine <b>3</b> was active (IC<sub>50</sub> = 10 nM) in the MET biochemical assay, the ELISA P-MET cell-based assay, and the proliferation assay using the MKN-45 <i>MET</i>-amplified gastric tumor cell line. Compound <b>3</b> was inactive on CDK9 (IC<sub>50</sub> > 10 μM) but still displayed affinity toward tubulin (IC<sub>50</sub> = 2 μM).</p><p>To unravel the molecular interactions responsible for the kinase activity observed, we initiated structural characterization of compound <b>3</b> bound to the WT MET kinase domain. Cocrystals were grown, X-ray diffraction data collected (1.6 Å resolution at the ESRF synchrotron 14-2 beamline in Grenoble, France), and the 3D structure of the complex was determined. Structure analysis revealed that compound <b>3</b> binds to the kinase ATP pocket, forming two H-bonds with the hinge region (Met1160, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). In addition, one of the nitrogen atoms of the triazolopyridazine moiety interacts with the main-chain nitrogen atom of Asp1222. The triazolopyridazine ring makes a π–π interaction with Tyr1230 of the activation loop positioned in a nonactive conformation. This binding mode is a structural feature of the so-called type I inhibitors, as exemplified by crizotinib and other triazolopyridazine/triazolopyridine-bearing MET inhibitors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structures of WT MET with <b>3</b> (A) and of MET-Y1230H with <b>14</b> (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>On the basis of the cocrystal structure of <b>3</b> bound to MET kinase, chemical modifications were designed and performed to simultaneously improve (i) the potency against WT MET and MET mutant proteins, (ii) the selectivity (among kinases and vs tubulin), and (iii) the aqueous thermodynamic solubility. The last physicochemical property was assessed under two conditions, in pure buffer (intrinsic solubility) and with a cosolvent (labrasol) as a preliminary formulation. In the course of the optimization program the benzothiazole subseries (e.g., compound <b>4</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) stood out as more attractive than the corresponding benzimidazoles, since it was not binding to tubulin (IC<sub>50</sub> > 25 μM) and had no Ames alert (compound <b>3</b> was found to be Ames positive). However, switching to the benzothiazole series was at risk from a druggability standpoint, as compound <b>4</b> was more lipophilic compared to <b>3</b> (log <i>D</i> = 4.6 versus 3.8) and exhibited decreased aqueous solubility in the conditions tested.</p><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Activities on Wild-Type MET, Biochemical Activity on MET Mutants, and Aqueous Solubility of Benzothiazole Derivatives <b>4</b>–<b>14</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> measured using phosphorylated protein in a biochemical assay.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> for cell-based P-MET, using an ELISA assay and MKN-45 cell line.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> measured in proliferation assay using MKN-45 cell line.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> measured using MET mutants in a biochemical assay. See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf" class="ext-link">Supporting Information</a> for details on assays indicated in table footnotes a–d.</p></div><div class="footnote" id="t1fn6"><sup>Table e</sup><p class="last">Measured experimentally by high performance liquid chromatography (HPLC) (Xterra MS C18 column).</p></div><div class="footnote" id="t1fn7"><sup>Table f</sup><p class="last">Equilibrated solubility measured in phosphate buffer with and without 10% Labrasol.</p></div><div class="footnote" id="t1fn8"><sup>Table g</sup><p class="last">Compounds were prepared according to the methods in the reference cited.</p></div></div><div></div></div><p>Various chemical moieties (carbamates, amines, amides, and ureas) were introduced in position 2 of the benzothiazole scaffold allowing at least a double interaction with the hinge region of the kinase (R1 group in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Most of the modifications depicted in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were well tolerated leading to potent kinase inhibitions in the biochemical assay, which consistently translated into significant P-MET inhibition in the cell-based assay, as well as antiproliferative activity on the <i>MET</i>-amplified MKN-45 cell line (IC<sub>50</sub> values of 10–100 nM). Although these compounds were found to be significantly active against the M1250T mutant, they were revealed to be less potent when considering L1195V and Y1230H mutants (see compounds <b>4</b>, <b>5</b>, <b>6</b>, <b>7</b> vs <b>8</b> and <b>9</b> in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Interestingly, the most catalytically active mutants were also the most sensitive ones (data not shown). In addition submicromolar inhibition of the Y1230H mutant was achieved only with compounds that were active at least in the nanomolar range against WT MET protein (compounds <b>9</b>, <b>12</b>, and <b>13</b>). From a structure–potency relationship point of view, introduction of a third interaction between the additional nitrogen atom brought by the urea group and the hinge does not explain the observed gain of activity for ureas <b>12</b> and <b>13</b> (compared to <b>4</b>), since cyclopropylamide <b>9</b> is equipotent to ureas <b>12</b> and <b>13</b>. To better understand the thermodynamics of binding in the selected series, we performed isothermal titration calorimetry (ITC) measurements<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with a series of analogs including the most active compound <b>12</b>. In general, a good correlation was observed between the biochemical IC<sub>50</sub> and the <i>K</i><sub>d</sub> obtained by calorimetry (e.g., <i>K</i><sub>d</sub> = 0.9 nM vs IC<sub>50</sub> = 4 nM for <b>12</b>). The free energy of binding of compound <b>12</b> to the WT protein was measured experimentally and found to be totally driven by the enthalpy contribution (Δ<i>G</i> = Δ<i>H</i>= −12.6 kcal/mol), a trend shared by the different triazolopyridazine compounds tested and in contrast to the ITC profile of crizotinib (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</p><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of key compounds with biochemical and ITC data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>This raised the hypothesis that potency was directly dependent on the number of hydrogen bonds, van der Waals interactions, and hydrophobic contacts<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> the inhibitor could establish with the protein. To gain insight on improving the affinity for MET mutants, cocrystallization attempts with compound <b>12</b> were performed on Y1230H, L1195V, and M1250T mutant proteins and with MET WT as well. Surprisingly, whereas the WT protein did not yield any crystals, 3D structures were readily obtained with the different MET mutants. Structural analysis of different complexes with <b>12</b> revealed four conserved major hydrogen bonds, three developed with Met1160 and Lys1161 of the hinge and one with Asp1222 of the DFG motif (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</p><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>12</b> in the Y1230H mutant showing the tight interaction with the hinge and the DFG Asp1222.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>On the other hand, the activation loop segment containing residue 1230 was not visible in any structure with <b>12</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf" class="ext-link">Supporting Information</a>). Similar to the 3D structure of <b>3</b> in WT MET protein, the mutated proteins were locked in a DFG in, α-C helix out conformation with a disrupted salt bridge between catalytic Lys1110 and α-C helix Glu1127.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Nonvisibility of the H1230 residue bearing segment in the MET Y1230H cocrystal structure raised the question of whether reduced affinity of compound <b>12</b> (and other analogs) for this mutant might be linked to a suboptimal π–π interaction of the triazolopyridazine core with the imidazole ring of H1230. This hypothesis was confirmed when compound <b>14</b> (analog of <b>12</b>) was successfully cocrystallized in the MET Y1230H mutant, the structure of the complex showing a clear positioning of the histidine residue in the electron density maps (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). In this crystal structure, the triazolopyridazine plane is twisted outward by ∼20° with respect to other analogs, thus placing the thiophene ring roughly parallel to H1230. Also observed is a slight shift of H1230 (∼1 Å) toward the solvent compared to Y1230 as seen in other WT MET structures. High potency of <b>14</b> against MET Y1230H mutant (IC<sub>50</sub> = 23 nM) could then be explained by favorable hydrophobic contacts between H1230 and the triazolopyridazine-thiophene segment (extended π-system). This hydrophobic interaction is likely enhanced by the planarity of the triazolopyridazine-thiophene segment, whereas the skewed nature of the triazolopyridazine-<i>p</i>-fluorophenyl observed in <b>3</b> probably also precludes a productive contact in <b>12</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf" class="ext-link">Supporting Information</a>).</p><p>This observation prompted us to initiate a second round of chemical optimization with modifications of the substituent linked to the triazolopyridazine core. The main purpose was to identify alternative replacements of the thiophene and significantly improve the aqueous solubility. The reported activities and druglike properties (solubility, permeability in Caco-2 cells, metabolic stability on human microsomes, reversible and irreversible inhibition of CYP3A4) are shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</p><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Multiparametric Analysis of Morpholino Ethylurea Analogs<a onclick="showRef(event, 'ref26 ref30'); return false;" href="javascript:void(0);" class="ref ref26 ref30">(26, 30)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> measured using prephosphorylated wild-type MET kinase domain in a biochemical assay.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> measured using MET mutant Y1230H in a biochemical assay.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Equilibrated solubility measured in phosphate buffer with and without 10% Labrasol.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Transepithelial transport across Caco-2/TC-7 monolayers (<i>P</i><sub>app</sub> = 10<sup>–7</sup> cm·s<sup>–1</sup>).</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Percentage of oxidative metabolism using hepatic microsomal fraction (20 min incubation, 1 mg/mL microsomes, 5 μM substrate).</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">IC<sub>50</sub> measured using recombinant human CYP3A4 with 7-benzyloxyquinoline as substrate.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">Negative slope values in %/min reflect potency of the mechanism-based inhibition. “No*” indicates that for IC<sub>50</sub> higher than 100 μM, no slopes can be determined, and it is defined as not quantifiable.</p></div><div class="footnote" id="t2fn8"><sup>Table h</sup><p class="last">Compounds were prepared according to the methods in the references cited. See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf" class="ext-link">Supporting Information</a> for details on assays in table footnotes a, b, d, e, f.</p></div></div><div></div></div><p>Compared to compound <b>15</b> (R2 = H), most of the substituents that were introduced led to potent analogs against the WT MET protein, having variable activity against the MET Y1230H mutant. The lack of permeability observed in the Caco-2 assay (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) could be attributed to several unfavorable factors like high molecular weight (in general around 550 g/mol), high number of H-bond acceptors (at least 10 as in <b>15</b>), and low intrinsic aqueous solubility, in spite of the balanced morpholino group basicity (pka =6.5) suitable for passive diffusion.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In contrast, 6-<i>O</i>-alky analogs showed good to moderate Caco-2 permeability (compounds <b>18</b>, <b>23</b>, and <b>24</b>). It remained unclear how to rationalize this observation, since these molecules exceed molecular weight (MW) of 500 g/mol, display 11 H-bond acceptors, and besides <b>13</b> and <b>26</b>, have the highest number of rotatable bonds (7) of this set of compounds.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In line with the Caco-2 results, compounds <b>18</b> and <b>23</b> exhibited moderate bioavailability in mouse PK studies (17% and 12%, respectively) as observed finally with many other extended rule of 5 (Ro5) compliant molecules.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Unfortunately, these molecules were discarded due to their inhibitory activity on the CYP3A4 isoform in a time-dependent manner (mechanism-based inhibition). Overall, taking into account the properties of R2 derivatives reported in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, compound <b>12</b> turned out to be the best compromise in terms of potency and druglike properties in particular regarding CYP450 inhibition. In the end, attempts to improve solubility in this chemical series failed as key atoms interacting with the MET proteins also proved to be involved in strong packing forces in compound solid states. The single crystal X-ray structure (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) of one polymorph of <b>12</b> attested to the dense packing of this solid state. The two flat conjugated π-systems disposed in a right angle configuration by the sulfur linker displayed stabilizing H-bond, lipophilic, and π-stacking interactions (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf" class="ext-link">Supporting Information</a>).</p><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Unit cell and packing views in the X-ray single crystal diffraction structure of <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>In PK studies in mice, the oral bioavailability of <b>12</b> was low (∼2%), in line with its moderate Caco-2 permeability. Hence, <b>12</b> was progressed toward in vivo preclinical studies as a parenteral agent for the treatment of MET-dependent cancer.</p><p>The pharmacokinetic and pharmacodynamic properties of compound <b>12</b> were first documented in female SCID mice bearing xenograft tumors based on the <i>MET</i>-amplified Hs 746T human gastric tumor cell line. To this end, a single intravenous administration at 20 mg/kg was performed. Compound <b>12</b> concentration was measured in both plasma and tumor tissue. The plasma exposure of <b>12</b> (area under the curve (AUC)) was 6190 h·ng/mL, the clearance moderate (CL = 3.1 L h<sup>–1</sup> kg<sup>–1</sup>), and the volume of distribution was large (<i>V</i><sub>ss</sub> = 4.2 L/kg). A rapid and sustained uptake of <b>12</b> in tumor tissue was observed, associated with a slower decrease of compound <b>12</b> concentration from tumor tissue compared to the plasma concentration. These results indicate a higher tumor to plasma exposure of <b>12</b> (with a tumor to plasma AUC ratio equal to 8.1; <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A).</p><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetic/pharmacodynamic (PK/PD) study of compound <b>12</b> in mice bearing xenograft tumor of the <i>MET</i>-amplified Hs 746T human gastric tumor cell line. Mice bearing established subcutaneous tumors derived from Hs 746T gastric cancer cell line were administered a single 20 mg/kg dose of <b>12</b> iv in the tail vein. The pharmacokinetic parameters of <b>12</b> were assessed by analysis of the drug concentrations in plasma and tumor tissue (A). The pharmacodynamic effect on MET kinase was assessed by analysis of phospho-MET(Y1349) levels in tumor extracts using Meso Scale Discovery (MSD) immunoassay (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Pharmacodynamic analysis in tumor tissue demonstrated a time-dependent reduction of MET kinase activity. Following administration of <b>12</b> at 20 mg/kg, phospho-MET(Y1349) evaluation in tumor extracts revealed that MET kinase inhibition was complete at 4 h (96%), significant at 24 h (80%), and partial at 48 h (61%) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). A direct relationship was observed between PD modulation and tumor concentration of <b>12</b> rather than with plasma concentration in this murine model. Significant P-MET inhibition at 24 h was associated with compound concentration of about 300 ng/mL in the tumor which represented an unbound drug exposure of about 2 nM above the IC<sub>50</sub> estimated in vitro vs Hs 746T cell lines (1 nM). It is worth mentioning that high protein binding of <b>12</b> in plasma (99.67%) did not prevent the molecule from distributing to the tumor tissue. This pharmacodynamic impact translated into tumor regression, as previously described.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p><p>The PK parameters of <b>12</b> were further characterized at lower intravenous doses in mice, rats, and dogs (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In all three species evaluated the clearance was moderate. The plasma terminal elimination half-life (<i>t</i><sub>1/2</sub>) was moderate (rats and dogs) to long (mice). The volume of distribution at steady state was moderate in dogs and large in rodents. The potential large tissue distribution in rodents was further confirmed by performing a tissue distribution study in rats, with an infusion of 25 mg/kg [<sup>14</sup>C]-<b>12</b>. Radioactivity was widely distributed throughout the whole body with maximum radioactivity concentrations reached in most tissues at the end of the infusion (i.e., 1 h) or 2 h after the start of infusion. Taken together, these results indicate a large distribution into the tumor tissue.</p><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Main PK Parameters of <b>12</b> Given Intravenously in Preclinical Models</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose, mg/kg (iv)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (L h<sup>–1</sup> g<sup>–1</sup>)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (% of blood flow)</td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">3.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Mean PK parameters in three female (mice and dogs) or male (rats) animals.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Plasma CL for animal species (blood/plasma ratio of 0.86).</p></div></div></div><p>Preliminary PK analysis from the phase I clinical trial<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> indicated that compound <b>12</b> blood exposure (AUC) increased proportionally from 50 to 740 mg/m<sup>2</sup>. After the first administration, the concentrations decreased over time with a terminal half-life of 15.9 h. Compound <b>12</b> exhibited a medium blood clearance (mean 33.9 L/h corresponding to approximately 0.5 L h<sup>–1</sup> kg<sup>–1</sup>, coefficient of variation (CV) of 38%), representing approximately 37% of the hepatic blood flow (87 L/h) and a large volume of distribution at steady state (mean 505 L corresponding to approximately 7.2 L/kg, CV = 99%).</p><p>Taken together, the disposition of <b>12</b> was assessed in a range of animal species, and the distribution and elimination processes documented in animals are consistent with the disposition observed in humans. Thus, the animal pharmacological models tested were likely to be predictive for efficacy of <b>12</b> in patients.</p><p class="last">In conclusion, the chemical optimization of a focused-screen hit, supported by structural analysis, led to the identification of compound <b>12</b>, a very potent and selective MET kinase inhibitor with favorable druggability properties for intravenous administration, and sustained target engagement in a <i>MET</i>-amplified tumor model. Overall, the compound profile being compatible with a weekly schedule of administration, further development with iv route was initiated, since some patients (e.g., MET-amplified esophagogastric adenocarcinoma) could prefer an iv infusion to an oral tablet. It is also possible that a less frequent dosing (weekly) versus a repeated format (daily) would trigger less acquired resistance to such treatment. A favorable tolerance profile was observed in phase I patients, with a dose escalation performed up to the MAD of 740 mg/m<sup>2</sup> (MTD of 570 mg/m<sup>2</sup>). Early evidence of antitumor activity triggered the evaluation of compound <b>12</b> in a phase II clinical trial in <i>MET</i>-amplified NSCLC patients (NCT02435121).</p><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00280">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00280" class="ext-link">10.1021/acs.jmedchem.6b00280</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis of SAR125844, overlay of structures, SMILES codes and data, and view of packing (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES codes and calculated molecular properties (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf">jm6b00280_si_001.pdf (783.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_002.csv">jm6b00280_si_002.csv (2.06 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited in the Protein Data Bank, <a href="http://www.pdb.org" class="extLink">www.pdb.org</a>, with the following PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HLW">5HLW</a> (compound <b>14</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HNI">5HNI</a> (compound <b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HO6">5HO6</a> (SAR125844-Y1230H), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOA">5HOA</a> (SAR125844-L1195V), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOR">5HOR</a> (SAR125844-M1250T).</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00280" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Schio</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5b373a2e293e352f7528383332341b283a35343d3275383436"><span class="__cf_email__" data-cfemail="ec808d999e898298c29f8f848583ac9f8d82838a85c28f8381">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Ugolini</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mireille Kenigsberg</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexey Rak</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francois Vallée</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacques Houtmann</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maryse Lowinski</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cécile Capdevila</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean Khider</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Albert</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathalie Martinet</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Conception Nemecek</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandrine Grapinet</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Bacqué</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manfred Roesner</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Delaisi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loreley Calvet</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice Bonche</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dorothée Semiond</span> - <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Coumaran Egile</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hélène Goulaouic</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry, ‡Oncology Drug Discovery, §Structure Design & Informatics, and ∥Protein Science
& Technology, Sanofi, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France</span>; 
    <span class="hlFld-Affiliation affiliation">Disposition,
Safety and Animal Research, Sanofi, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin, France</span>; 
    <span class="hlFld-Affiliation affiliation">Sanofi-Aventis
Germany GmbH, Industriepark
Hoechst, 65926 Frankfurt
am Main, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">This article is dedicated to the memory of our colleagues Jean-Yves Crenne (Protein Science & Technology, Sanofi) and Dominique Damour (Medicinal Chemistry, Sanofi).</p><br /></br><p class="inlineNote">The 3D views presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf" class="ext-link">Supporting Information</a> were generated using BIOVIA Discovery Studio 4.5/2016 software and Cambridge Crystallographic Data Centre Mercury CFC 3.7.</p></div></li></ul></div><div class="ack" id="ACK-d124e1267-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Anne Dagallier (Structure Design & Informatics, Sanofi) and Hélène de Foucauld (Structure Design & Informatics, Sanofi) for modeling studies and Jacques Dumas (Protein Science & Technology, Sanofi) and Francis Duffieux (Protein Science & Technology, Sanofi) for proofreading.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i12" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i12"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i13" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i13"> Abbreviations Used</h2><tr><td class="NLM_term">HGF</td><td class="NLM_def"><p class="first last">hepatocyte growth factor</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">colorectal cancer</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamic</p></td></tr><tr><td class="NLM_term">DFG</td><td class="NLM_def"><p class="first last">Asp-Phe-Gly</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">MSD</td><td class="NLM_def"><p class="first last">Meso Scale Discovery</p></td></tr><tr><td class="NLM_term">CV</td><td class="NLM_def"><p class="first last">coefficient of variation</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">MET signaling: principles and functions in development, organ regeneration and cancer</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/nrm3012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fnrm3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21102609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=834-848&author=L.+Trusolinoauthor=A.+Bertottiauthor=P.+M.+Comoglio&title=MET+signaling%3A+principles+and+functions+in+development%2C+organ+regeneration+and+cancer&doi=10.1038%2Fnrm3012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">MET signalling: principles and functions in development, organ regeneration and cancer</span></div><div class="casAuthors">Trusolino, Livio; Bertotti, Andrea; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">834-848</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The MET tyrosine kinase receptor (also known as the HGF receptor) promotes tissue remodelling, which underlies developmental morphogenesis, wound repair, organ homeostasis and cancer metastasis, by integrating growth, survival and migration cues in response to environmental stimuli or cell-autonomous perturbations.  The versatility of MET-mediated biol. responses is sustained by qual. and quant. signal modulation.  Qual. mechanisms include the engagement of dedicated signal transducers and the subcellular compartmentalization of MET signalling pathways, whereas quant. regulation involves MET partnering with adaptor amplifiers or being degraded through the shedding of its extracellular domain or through intracellular ubiquitylation.  Controlled activation of MET signalling can be exploited in regenerative medicine, whereas MET inhibition might slow down tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzaWXvEKEpVrVg90H21EOLACvtfcHk0lhSyKaudSAk8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI&md5=c97f7b6ff2522bc0d20d0371d07c5ea2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3012%26sid%3Dliteratum%253Aachs%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DMET%2520signaling%253A%2520principles%2520and%2520functions%2520in%2520development%252C%2520organ%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D834%26epage%3D848%26doi%3D10.1038%2Fnrm3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G.</span><span> </span><span class="NLM_article-title">Targeting MET in cancer: rationale and progress</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1038/nrc3205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fnrc3205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=22270953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=89-103&author=E.+Gherardiauthor=W.+Birchmeierauthor=C.+Birchmeierauthor=G.+Vande+Woude&title=Targeting+MET+in+cancer%3A+rationale+and+progress&doi=10.1038%2Fnrc3205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MET in cancer: rationale and progress</span></div><div class="casAuthors">Gherardi, Ermanno; Birchmeier, Walter; Birchmeier, Carmen; Vande Woude, George</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-103</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of cancer.  Genetic and biochem. data have demonstrated that the growth and motility factor hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, the tyrosine kinase MET, have a causal role in all of these processes, thus providing a strong rationale for targeting these mols. in cancer.  Parallel progress in understanding the structure and function of HGF/SF, MET and assocd. signalling components has led to the successful development of blocking antibodies and a large no. of small-mol. MET kinase inhibitors.  In this Review, we discuss these advances, as well as results from recent clin. studies that demonstrate that inhibiting MET signalling in several types of solid human tumors has major therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6JxJEFNd5E7Vg90H21EOLACvtfcHk0lhSyKaudSAk8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSmu7s%253D&md5=ea16195614f1dd385ed48fd29bad9a8d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc3205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3205%26sid%3Dliteratum%253Aachs%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DVande%2BWoude%26aufirst%3DG.%26atitle%3DTargeting%2520MET%2520in%2520cancer%253A%2520rationale%2520and%2520progress%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D89%26epage%3D103%26doi%3D10.1038%2Fnrc3205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bladt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riethmacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isenmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span><span class="refDoi"> DOI: 10.1038/376768a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2F376768a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=768-771&author=F.+Bladtauthor=D.+Riethmacherauthor=S.+Isenmannauthor=A.+Aguzziauthor=C.+Birchmeier&title=Essential+role+for+the+c-met+receptor+in+the+migration+of+myogenic+precursor+cells+into+the+limb+bud&doi=10.1038%2F376768a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F376768a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376768a0%26sid%3Dliteratum%253Aachs%26aulast%3DBladt%26aufirst%3DF.%26aulast%3DRiethmacher%26aufirst%3DD.%26aulast%3DIsenmann%26aufirst%3DS.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DEssential%2520role%2520for%2520the%2520c-met%2520receptor%2520in%2520the%2520migration%2520of%2520myogenic%2520precursor%2520cells%2520into%2520the%2520limb%2520bud%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D768%26epage%3D771%26doi%3D10.1038%2F376768a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Huh, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Factor, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, S. S.</span><span> </span><span class="NLM_article-title">Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">4477</span><span class="NLM_x">–</span> <span class="NLM_lpage">4482</span><span class="refDoi"> DOI: 10.1073/pnas.0306068101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0306068101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=4477-4482&issue=13&author=C.+G.+Huhauthor=V.+M.+Factorauthor=A.+S%C3%A1nchezauthor=K.+Uchidaauthor=E.+A.+Connerauthor=S.+S.+Thorgeirsson&title=Hepatocyte+growth+factor%2Fc-met+signaling+pathway+is+required+for+efficient+liver+regeneration+and+repair&doi=10.1073%2Fpnas.0306068101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0306068101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0306068101%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DC.%2BG.%26aulast%3DFactor%26aufirst%3DV.%2BM.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DConner%26aufirst%3DE.%2BA.%26aulast%3DThorgeirsson%26aufirst%3DS.%2BS.%26atitle%3DHepatocyte%2520growth%2520factor%252Fc-met%2520signaling%2520pathway%2520is%2520required%2520for%2520efficient%2520liver%2520regeneration%2520and%2520repair%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D13%26spage%3D4477%26epage%3D4482%26doi%3D10.1073%2Fpnas.0306068101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Borowiak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüstefeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trautwein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Met provides essential signals for liver regeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">10608</span><span class="NLM_x">–</span> <span class="NLM_lpage">10613</span><span class="refDoi"> DOI: 10.1073/pnas.0403412101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0403412101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10608-10613&issue=29&author=M.+Borowiakauthor=A.+N.+Garrattauthor=T.+W%C3%BCstefeldauthor=M.+Strehleauthor=C.+Trautweinauthor=C.+Birchmeier&title=Met+provides+essential+signals+for+liver+regeneration&doi=10.1073%2Fpnas.0403412101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0403412101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0403412101%26sid%3Dliteratum%253Aachs%26aulast%3DBorowiak%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DW%25C3%25BCstefeld%26aufirst%3DT.%26aulast%3DStrehle%26aufirst%3DM.%26aulast%3DTrautwein%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DMet%2520provides%2520essential%2520signals%2520for%2520liver%2520regeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D29%26spage%3D10608%26epage%3D10613%26doi%3D10.1073%2Fpnas.0403412101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Schmidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duh, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choyke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubensky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allikmets, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chidambaram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerheim, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltis, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamarron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernues, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lips, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orcutt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stackhouse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slife, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niehans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storkel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerman, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zbar, B.</span><span> </span><span class="NLM_article-title">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1038/ng0597-68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fng0597-68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=9140397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=68-73&issue=1&author=L.+Schmidtauthor=F.+M.+Duhauthor=F.+Chenauthor=T.+Kishidaauthor=G.+Glennauthor=P.+Choykeauthor=S.+W.+Schererauthor=Z.+Zhuangauthor=I.+Lubenskyauthor=M.+Deanauthor=R.+Allikmetsauthor=A.+Chidambaramauthor=U.+R.+Bergerheimauthor=J.+T.+Feltisauthor=C.+Casadevallauthor=A.+Zamarronauthor=M.+Bernuesauthor=S.+Richardauthor=C.+J.+Lipsauthor=M.+M.+Waltherauthor=L.+C.+Tsuiauthor=L.+Geilauthor=M.+L.+Orcuttauthor=T.+Stackhouseauthor=J.+Lipanauthor=L.+Slifeauthor=H.+Brauchauthor=J.+Deckerauthor=G.+Niehansauthor=M.+D.+Hughsonauthor=H.+Mochauthor=S.+Storkelauthor=M.+I.+Lermanauthor=W.+M.+Linehanauthor=B.+Zbar&title=Germline+and+somatic+mutations+in+the+tyrosine+kinase+domain+of+the+MET+proto-oncogene+in+papillary+renal+carcinomas&doi=10.1038%2Fng0597-68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span></div><div class="casAuthors">Schmidt, Laura; Duh, Fuh-Mei; Chen, Fan; Kishida, Takeshi; Glenn, Gladys; Choyke, Peter; Scherer, Stephen W.; Zhuang, Zhenping; Lubensky, Irina; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-73</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Hereditary papillary renal carcinoma (HPRC) is a recently recognized form of inherited kidney cancer characterized by a predisposition to develop multiple, bilateral papillary renal tumors.  The pattern of inheritance of HPRC is consistent with autosomal dominant transmission with reduced penetrance.  HPRC is histol. and genetically distinct from two other causes of inherited renal carcinoma, von Hippel-Lindau disease (VHL) and the chromosome translocation (3;8).  Malignant papillary renal carcinomas are characterized by trisomy of chromosomes 7, 16 and 17, and in men, by loss of the Y chromosome.  Inherited and sporadic clear cell renal carcinomas are characterized by inactivation of both copies of the VHL gene by mutation, and/or by hypermethylation.  We found that the HPRC gene was located at chromosome 7q31.1-34 in a 27-centimorgan (cM) interval between D7S496 and D7S1837.  We identified missense mutations located in the tyrosine kinase domain of the MET gene in the germline of affected members of HPRC families and in a subset of sporadic papillary renal carcinomas.  Three mutations in the MET gene are located in codons that are homologous to those in c-kit and RET, proto-oncogenes that are targets of naturally-occurring mutations.  The results suggest that missense mutations located in the MET proto-oncogene lead to constitutive activation of the MET protein and papillary renal carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-x_dqJPR-7Vg90H21EOLACvtfcHk0lgBC-KjUdbGsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D&md5=7209dbbaa538b418defad117830df3c9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng0597-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0597-68%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DDuh%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DKishida%26aufirst%3DT.%26aulast%3DGlenn%26aufirst%3DG.%26aulast%3DChoyke%26aufirst%3DP.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DLubensky%26aufirst%3DI.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DAllikmets%26aufirst%3DR.%26aulast%3DChidambaram%26aufirst%3DA.%26aulast%3DBergerheim%26aufirst%3DU.%2BR.%26aulast%3DFeltis%26aufirst%3DJ.%2BT.%26aulast%3DCasadevall%26aufirst%3DC.%26aulast%3DZamarron%26aufirst%3DA.%26aulast%3DBernues%26aufirst%3DM.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DLips%26aufirst%3DC.%2BJ.%26aulast%3DWalther%26aufirst%3DM.%2BM.%26aulast%3DTsui%26aufirst%3DL.%2BC.%26aulast%3DGeil%26aufirst%3DL.%26aulast%3DOrcutt%26aufirst%3DM.%2BL.%26aulast%3DStackhouse%26aufirst%3DT.%26aulast%3DLipan%26aufirst%3DJ.%26aulast%3DSlife%26aufirst%3DL.%26aulast%3DBrauch%26aufirst%3DH.%26aulast%3DDecker%26aufirst%3DJ.%26aulast%3DNiehans%26aufirst%3DG.%26aulast%3DHughson%26aufirst%3DM.%2BD.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DStorkel%26aufirst%3DS.%26aulast%3DLerman%26aufirst%3DM.%2BI.%26aulast%3DLinehan%26aufirst%3DW.%2BM.%26aulast%3DZbar%26aufirst%3DB.%26atitle%3DGermline%2520and%2520somatic%2520mutations%2520in%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520MET%2520proto-oncogene%2520in%2520papillary%2520renal%2520carcinomas%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D16%26issue%3D1%26spage%3D68%26epage%3D73%26doi%3D10.1038%2Fng0597-68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kong-Beltran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshagiri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhawe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holcomb, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwall, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yauch, R.</span><span> </span><span class="NLM_article-title">Somatic mutations lead to an oncogenic deletion of Met in lung cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F0008-5472.CAN-05-2749" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=283-289&issue=1&author=M.+Kong-Beltranauthor=S.+Seshagiriauthor=J.+Zhaauthor=W.+Zhuauthor=K.+Bhaweauthor=N.+Mendozaauthor=T.+Holcombauthor=K.+Pujaraauthor=J.+Stinsonauthor=L.+Fuauthor=C.+Severinauthor=L.+Rangellauthor=R.+Schwallauthor=L.+Amlerauthor=D.+Wickramasingheauthor=R.+Yauch&title=Somatic+mutations+lead+to+an+oncogenic+deletion+of+Met+in+lung+cancer&doi=10.1158%2F0008-5472.CAN-05-2749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2749%26sid%3Dliteratum%253Aachs%26aulast%3DKong-Beltran%26aufirst%3DM.%26aulast%3DSeshagiri%26aufirst%3DS.%26aulast%3DZha%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DBhawe%26aufirst%3DK.%26aulast%3DMendoza%26aufirst%3DN.%26aulast%3DHolcomb%26aufirst%3DT.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSeverin%26aufirst%3DC.%26aulast%3DRangell%26aufirst%3DL.%26aulast%3DSchwall%26aufirst%3DR.%26aulast%3DAmler%26aufirst%3DL.%26aulast%3DWickramasinghe%26aufirst%3DD.%26aulast%3DYauch%26aufirst%3DR.%26atitle%3DSomatic%2520mutations%2520lead%2520to%2520an%2520oncogenic%2520deletion%2520of%2520Met%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D1%26spage%3D283%26epage%3D289%26doi%3D10.1158%2F0008-5472.CAN-05-2749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skokan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajapathy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felicioni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Grammastro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciarrotta, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttitta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incarbone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toschi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloisio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span> </span><span class="NLM_article-title">Increased MET gene copy number negatively affects survival of surgically resected non-small cell lung cancer patients</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span><span class="refDoi"> DOI: 10.1200/JCO.2008.19.1635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1200%2FJCO.2008.19.1635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=19255323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ktlKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1667-1674&issue=10&author=F.+Cappuzzoauthor=A.+Marchettiauthor=M.+Skokanauthor=E.+Rossiauthor=S.+Gajapathyauthor=L.+Felicioniauthor=M.+Del+Grammastroauthor=M.+G.+Sciarrottaauthor=F.+Buttittaauthor=M.+Incarboneauthor=L.+Toschiauthor=G.+Finocchiaroauthor=A.+Destroauthor=L.+Terraccianoauthor=M.+Roncalliauthor=M.+Alloisioauthor=A.+Santoroauthor=M.+Varella-Garcia&title=Increased+MET+gene+copy+number+negatively+affects+survival+of+surgically+resected+non-small+cell+lung+cancer+patients&doi=10.1200%2FJCO.2008.19.1635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients</span></div><div class="casAuthors">Cappuzzo Federico; Marchetti Antonio; Skokan Margaret; Rossi Elisa; Gajapathy Sujatha; Felicioni Lara; Del Grammastro Maela; Sciarrotta Maria Grazia; Buttitta Fiamma; Incarbone Matteo; Toschi Luca; Finocchiaro Giovanna; Destro Annarita; Terracciano Luigi; Roncalli Massimo; Alloisio Marco; Santoro Armando; Varella-Garcia Marileila</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1667-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To investigate the prognostic role of genomic gain for MET and epidermal growth factor receptor (EGFR) genes in surgically resected non-small-cell lung cancer (NSCLC).  PATIENTS AND METHODS:  This retrospective study included 447 NSCLC patients with available tumor tissue from primary lung tumor and survival data.  EGFR and MET status was evaluated by fluorescent in situ hybridization (FISH) in tissue microarray sections.  RESULTS:  EGFR FISH results were obtained in 376 cases.  EGFR gene amplification and high polysomy (EGFR FISH+) were observed in 10.4% and 32.4% of cases, respectively.  EGFR FISH-positive patients had a nonsignificant shorter survival than EGFR FISH-negative patients (P = .4).  Activating EGFR mutations were detected in 9.7% of 144 stage I-II disease with no impact on survival.  MET FISH analysis was performed in 435 cases.  High MET gene copy number (mean > or = 5 copies/cell) was observed in 48 cases (MET+, 11.1%), including 18 cases with true gene amplification (4.1%).  MET+ status was associated with advanced stage (P = .01), with grade 3 (P = .016) and with EGFR FISH+ result (P < .0001).  No patient with activating EGFR mutation resulted MET+.  In the whole population, MET-positive patients had shorter survival than MET-negative patients (P = .005).  Multivariable model confirmed that MET-negative patients had a significant reduction in the risk of death than MET-positive patients (hazard ratio, 0.66; P = .04).  CONCLUSION:  MET increased gene copy number is an independent negative prognostic factor in surgically resected NSCLC.  EGFR gene gain does not impact survival after resection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnc5G-Os6-WzdblLE_E9PWfW6udTcc2eZ0eLOsqPjgLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ktlKruw%253D%253D&md5=41bfbb70eb8a9e4ffd2964caf68e2511</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.19.1635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.19.1635%26sid%3Dliteratum%253Aachs%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DSkokan%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DE.%26aulast%3DGajapathy%26aufirst%3DS.%26aulast%3DFelicioni%26aufirst%3DL.%26aulast%3DDel%2BGrammastro%26aufirst%3DM.%26aulast%3DSciarrotta%26aufirst%3DM.%2BG.%26aulast%3DButtitta%26aufirst%3DF.%26aulast%3DIncarbone%26aufirst%3DM.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DDestro%26aufirst%3DA.%26aulast%3DTerracciano%26aufirst%3DL.%26aulast%3DRoncalli%26aufirst%3DM.%26aulast%3DAlloisio%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26atitle%3DIncreased%2520MET%2520gene%2520copy%2520number%2520negatively%2520affects%2520survival%2520of%2520surgically%2520resected%2520non-small%2520cell%2520lung%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26issue%3D10%26spage%3D1667%26epage%3D1674%26doi%3D10.1200%2FJCO.2008.19.1635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsudomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span> </span><span class="NLM_article-title">MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1043</span><span class="refDoi"> DOI: 10.1126/science.1141478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1126%2Fscience.1141478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=17463250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1039-1043&author=J.+A.+Engelmanauthor=K.+Zejnullahuauthor=T.+Mitsudomiauthor=Y.+Songauthor=C.+Hylandauthor=J.+O.+Parkauthor=N.+Lindemanauthor=C.+M.+Galeauthor=X.+Zhaoauthor=J.+Christensenauthor=T.+Kosakaauthor=A.+J.+Holmesauthor=A.+M.+Rogersauthor=F.+Cappuzzoauthor=T.+Mokauthor=C.+Leeauthor=B.+E.+Johnsonauthor=L.+C.+Cantleyauthor=P.+A.+J%C3%A4nne&title=MET+amplification+leads+to+gefitinib+resistance+in+lung+cancer+by+activating+ERBB3+signaling&doi=10.1126%2Fscience.1141478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling</span></div><div class="casAuthors">Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Song, Youngchul; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Zhao, Xiaojun; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; Rogers, Andrew M.; Cappuzzo, Federico; Mok, Tony; Lee, Charles; Johnson, Bruce E.; Cantley, Lewis C.; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5827</span>),
    <span class="NLM_cas:pages">1039-1043</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance.  Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib.  MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib.  We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors.  Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr430gbvBeIoLVg90H21EOLACvtfcHk0lj2JEUa7SpHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D&md5=3da9383b4acb965f57529b095f8f4686</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1141478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1141478%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMitsudomi%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DJ.%2BO.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DGale%26aufirst%3DC.%2BM.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DRogers%26aufirst%3DA.%2BM.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DMok%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DMET%2520amplification%2520leads%2520to%2520gefitinib%2520resistance%2520in%2520lung%2520cancer%2520by%2520activating%2520ERBB3%2520signaling%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1039%26epage%3D1043%26doi%3D10.1126%2Fscience.1141478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bean, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riely, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szoke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladanyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">20932</span><span class="NLM_x">–</span> <span class="NLM_lpage">20937</span><span class="refDoi"> DOI: 10.1073/pnas.0710370104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0710370104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=18093943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=20932-20937&author=J.+Beanauthor=C.+Brennanauthor=J.+Y.+Shihauthor=G.+Rielyauthor=A.+Vialeauthor=L.+Wangauthor=D.+Chitaleauthor=N.+Motoiauthor=J.+Szokeauthor=S.+Broderickauthor=M.+Balakauthor=W.+C.+Changauthor=C.+J.+Yuauthor=A.+Gazdarauthor=H.+Passauthor=V.+Ruschauthor=W.+Geraldauthor=S.+F.+Huangauthor=P.+C.+Yangauthor=V.+Millerauthor=M.+Ladanyiauthor=C.+H.+Yangauthor=W.+Pao&title=MET+amplification+occurs+with+or+without+T790M+mutations+in+EGFR+mutant+lung+tumors+with+acquired+resistance+to+gefitinib+or+erlotinib&doi=10.1073%2Fpnas.0710370104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Met amplification occurs with or without T790m mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib</span></div><div class="casAuthors">Bean, James; Brennan, Cameron; Shih, Jin-Yuan; Riely, Gregory; Viale, Agnes; Wang, Lu; Chitale, Dhananjay; Motoi, Noriko; Szoke, Janos; Broderick, Stephen; Balak, Marissa; Chang, Wen-Cheng; Yu, Chong-Jen; Gazdar, Adi; Pass, Harvey; Rusch, Valerie; Gerald, William; Huang, Shiu-Feng; Yang, Pan-Chyr; Miller, Vincent; Ladanyi, Marc; Yang, Chih-Hsin; Pao, William</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">20932-20937</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In human lung adenocarcinomas harboring EGFR mutations, a second-site point mutation that substitutes methionine for threonine at position 790 (T790M) is assocd. with approx. half of cases of acquired resistance to the EGFR kinase inhibitors, gefitinib and erlotinib.  To identify other potential mechanisms that contribute to disease progression, we used array-based comparative genomic hybridization (aCGH) to compare genomic profiles of EGFR mutant tumors from untreated patients with those from patients with acquired resistance.  Among three loci demonstrating recurrent copy no. alterations (CNAs) specific to the acquired resistance set, one contained the MET proto-oncogene.  Collectively, anal. of tumor samples from multiple independent patient cohorts revealed that MET was amplified in tumors from 9 of 43 (21%) patients with acquired resistance but in only two tumors from 62 untreated patients (3%) (P = 0.007, Fisher's Exact test).  Among 10 resistant tumors from the nine patients with MET amplification, 4 also harbored the EGFRT790M mutation.  We also found that an existing EGFR mutant lung adenocarcinoma cell line, NCI-H820, harbors MET amplification in addn. to a drug-sensitive EGFR mutation and the T790M change.  Growth inhibition studies demonstrate that these cells are resistant to both erlotinib and an irreversible EGFR inhibitor (CL-387,785) but sensitive to a multikinase inhibitor (XL880) with potent activity against MET.  Taken together, these data suggest that MET amplification occurs independently of EGFRT790M mutations and that MET may be a clin. relevant therapeutic target for some patients with acquired resistance to gefitinib or erlotinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVkBqKpZ-f97Vg90H21EOLACvtfcHk0lj2JEUa7SpHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlyhsg%253D%253D&md5=3c80cf95fd68733e20b469e79035e721</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710370104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710370104%26sid%3Dliteratum%253Aachs%26aulast%3DBean%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DShih%26aufirst%3DJ.%2BY.%26aulast%3DRiely%26aufirst%3DG.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChitale%26aufirst%3DD.%26aulast%3DMotoi%26aufirst%3DN.%26aulast%3DSzoke%26aufirst%3DJ.%26aulast%3DBroderick%26aufirst%3DS.%26aulast%3DBalak%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DW.%2BC.%26aulast%3DYu%26aufirst%3DC.%2BJ.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPass%26aufirst%3DH.%26aulast%3DRusch%26aufirst%3DV.%26aulast%3DGerald%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DS.%2BF.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DMiller%26aufirst%3DV.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DMET%2520amplification%2520occurs%2520with%2520or%2520without%2520T790M%2520mutations%2520in%2520EGFR%2520mutant%2520lung%2520tumors%2520with%2520acquired%2520resistance%2520to%2520gefitinib%2520or%2520erlotinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D20932%26epage%3D20937%26doi%3D10.1073%2Fpnas.0710370104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias-Santagata, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digumarthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turke, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergethon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosper, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhavanfard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heist, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernovsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanuti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">75ra26</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3002003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1126%2Fscitranslmed.3002003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21430269" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=75ra26&author=L.+V.+Sequistauthor=B.+A.+Waltmanauthor=D.+Dias-Santagataauthor=S.+Digumarthyauthor=A.+B.+Turkeauthor=P.+Fidiasauthor=K.+Bergethonauthor=A.+T.+Shawauthor=S.+Gettingerauthor=A.+K.+Cosperauthor=S.+Akhavanfardauthor=R.+S.+Heistauthor=J.+Temelauthor=J.+G.+Christensenauthor=J.+C.+Wainauthor=T.+J.+Lynchauthor=K.+Vernovskyauthor=E.+J.+Markauthor=M.+Lanutiauthor=A.+J.+Iafrateauthor=M.+Mino-Kenudsonauthor=J.+A.+Engelman&title=Genotypic+and+histological+evolution+of+lung+cancers+acquiring+resistance+to+EGFR+inhibitors&doi=10.1126%2Fscitranslmed.3002003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002003%26sid%3Dliteratum%253Aachs%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DWaltman%26aufirst%3DB.%2BA.%26aulast%3DDias-Santagata%26aufirst%3DD.%26aulast%3DDigumarthy%26aufirst%3DS.%26aulast%3DTurke%26aufirst%3DA.%2BB.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DBergethon%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DGettinger%26aufirst%3DS.%26aulast%3DCosper%26aufirst%3DA.%2BK.%26aulast%3DAkhavanfard%26aufirst%3DS.%26aulast%3DHeist%26aufirst%3DR.%2BS.%26aulast%3DTemel%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DWain%26aufirst%3DJ.%2BC.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DVernovsky%26aufirst%3DK.%26aulast%3DMark%26aufirst%3DE.%2BJ.%26aulast%3DLanuti%26aufirst%3DM.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DGenotypic%2520and%2520histological%2520evolution%2520of%2520lung%2520cancers%2520acquiring%2520resistance%2520to%2520EGFR%2520inhibitors%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D75ra26%26doi%3D10.1126%2Fscitranslmed.3002003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtorta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siravegna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartore-Bianchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassingena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zecchin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apicella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauricella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronese, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amatu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nicolantonio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siena, S.</span><span> </span><span class="NLM_article-title">Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F2159-8290.CD-12-0558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=23729478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=658-673&author=A.+Bardelliauthor=S.+Corsoauthor=A.+Bertottiauthor=S.+Hoborauthor=E.+Valtortaauthor=G.+Siravegnaauthor=A.+Sartore-Bianchiauthor=E.+Scalaauthor=A.+Cassingenaauthor=D.+Zecchinauthor=M.+Apicellaauthor=G.+Migliardiauthor=F.+Galimiauthor=C.+Lauricellaauthor=C.+Zanonauthor=T.+Pereraauthor=S.+Veroneseauthor=G.+Cortiauthor=A.+Amatuauthor=M.+Gambacortaauthor=L.+A.+Diazauthor=M.+Sausenauthor=V.+E.+Velculescuauthor=P.+Comoglioauthor=L.+Trusolinoauthor=F.+Di+Nicolantonioauthor=S.+Giordanoauthor=S.+Siena&title=Amplification+of+the+MET+receptor+drives+resistance+to+anti-EGFR+therapies+in+colorectal+cancer&doi=10.1158%2F2159-8290.CD-12-0558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer</span></div><div class="casAuthors">Bardelli, Alberto; Corso, Simona; Bertotti, Andrea; Hobor, Sebastijan; Valtorta, Emanuele; Siravegna, Giulia; Sartore-Bianchi, Andrea; Scala, Elisa; Cassingena, Andrea; Zecchin, Davide; Apicella, Maria; Migliardi, Giorgia; Galimi, Francesco; Lauricella, Calogero; Zanon, Carlo; Perera, Timothy; Veronese, Silvio; Corti, Giorgio; Amatu, Alessio; Gambacorta, Marcello; Diaz, Luis A., Jr; Sausen, Mark; Velculescu, Victor E.; Comoglio, Paolo; Trusolino, Livio; Di Nicolantonio, Federica; Giordano, Silvia; Siena, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">658-673</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">EGF receptor (EGFR)-targeted monoclonal antibodies are effective in a subset of metastatic colorectal cancers.  Inevitably, all patients develop resistance, which occurs through emergence of KRAS mutations in approx. 50% of the cases.  We show that amplification of the MET proto-oncogene is assocd. with acquired resistance in tumors that do not develop KRAS mutations during anti-EGFR therapy.  Amplification of the MET locus was present in circulating tumor DNA before relapse was clin. evident.  Functional studies show that MET activation confers resistance to anti-EGFR therapy both in vitro and in vivo.  Notably, in patient-derived colorectal cancer xenografts, MET amplification correlated with resistance to EGFR blockade, which could be overcome by MET kinase inhibitors.  These results highlight the role of MET in mediating primary and secondary resistance to anti-EGFR therapies in colorectal cancer and encourage the use of MET inhibitors in patients displaying resistance as a result of MET amplification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhBSlKSNbwu7Vg90H21EOLACvtfcHk0lhlgbcUFe3y2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOrt7Y%253D&md5=68e7b07e9b39644949db4e0d6fe63af9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0558%26sid%3Dliteratum%253Aachs%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCorso%26aufirst%3DS.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DHobor%26aufirst%3DS.%26aulast%3DValtorta%26aufirst%3DE.%26aulast%3DSiravegna%26aufirst%3DG.%26aulast%3DSartore-Bianchi%26aufirst%3DA.%26aulast%3DScala%26aufirst%3DE.%26aulast%3DCassingena%26aufirst%3DA.%26aulast%3DZecchin%26aufirst%3DD.%26aulast%3DApicella%26aufirst%3DM.%26aulast%3DMigliardi%26aufirst%3DG.%26aulast%3DGalimi%26aufirst%3DF.%26aulast%3DLauricella%26aufirst%3DC.%26aulast%3DZanon%26aufirst%3DC.%26aulast%3DPerera%26aufirst%3DT.%26aulast%3DVeronese%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DG.%26aulast%3DAmatu%26aufirst%3DA.%26aulast%3DGambacorta%26aufirst%3DM.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DSausen%26aufirst%3DM.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DComoglio%26aufirst%3DP.%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DSiena%26aufirst%3DS.%26atitle%3DAmplification%2520of%2520the%2520MET%2520receptor%2520drives%2520resistance%2520to%2520anti-EGFR%2520therapies%2520in%2520colorectal%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D658%26epage%3D673%26doi%3D10.1158%2F2159-8290.CD-12-0558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Straussman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barzily-Rokni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mongare, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wargo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span> </span><span class="NLM_article-title">Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1038/nature11183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fnature11183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=22763439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=500-504&author=R.+Straussmanauthor=T.+Morikawaauthor=K.+Sheeauthor=M.+Barzily-Rokniauthor=Z.+R.+Qianauthor=J.+Duauthor=A.+Davisauthor=M.+M.+Mongareauthor=J.+Gouldauthor=D.+T.+Frederickauthor=Z.+A.+Cooperauthor=P.+B.+Chapmanauthor=D.+B.+Solitauthor=A.+Ribasauthor=R.+S.+Loauthor=K.+T.+Flahertyauthor=S.+Oginoauthor=J.+A.+Wargoauthor=T.+R.+Golub&title=Tumour+micro-environment+elicits+innate+resistance+to+RAF+inhibitors+through+HGF+secretion&doi=10.1038%2Fnature11183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion</span></div><div class="casAuthors">Straussman, Ravid; Morikawa, Teppei; Shee, Kevin; Barzily-Rokni, Michal; Qian, Zhi Rong; Du, Jinyan; Davis, Ashli; Mongare, Margaret M.; Gould, Joshua; Frederick, Dennie T.; Cooper, Zachary A.; Chapman, Paul B.; Solit, David B.; Ribas, Antoni; Lo, Roger S.; Flaherty, Keith T.; Ogino, Shuji; Wargo, Jennifer A.; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7408</span>),
    <span class="NLM_cas:pages">500-504</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug resistance presents a challenge to the treatment of cancer patients.  Many studies have focused on cell-autonomous mechanisms of drug resistance.  By contrast, the authors proposed that the tumor micro-environment confers innate resistance to therapy.  Here the authors developed a co-culture system to systematically assay the ability of 23 stromal cell types to influence the innate resistance of 45 cancer cell lines to 35 anticancer drugs.  The authors found that stroma-mediated resistance is common, particularly to targeted agents.  The authors characterized further the stroma-mediated resistance of BRAF-mutant melanoma to RAF inhibitors because most patients with this type of cancer show some degree of innate resistance.  Proteomic anal. showed that stromal cell secretion of hepatocyte growth factor (HGF) resulted in activation of the HGF receptor MET, reactivation of the mitogen-activated protein kinase (MAPK), and phosphatidylinositol-3-OH kinase (PI(3)K)-AKT signaling pathways, and immediate resistance to RAF inhibition.  Immunohistochem. expts. confirmed stromal cell expression of HGF in patients with BRAF-mutant melanoma and showed a significant correlation between HGF expression by stromal cells and innate resistance to RAF inhibitor treatment.  Dual inhibition of RAF and either HGF or MET resulted in reversal of drug resistance, suggesting RAF plus HGF or MET inhibitory combination therapy as a potential therapeutic strategy for BRAF-mutant melanoma.  A similar resistance mechanism was uncovered in a subset of BRAF-mutant colorectal and glioblastoma cell lines.  More generally, this study indicates that the systematic dissection of interactions between tumors and their micro-environment can uncover important mechanisms underlying drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwanlhJUTP4LVg90H21EOLACvtfcHk0lhlgbcUFe3y2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjtL3J&md5=0616b5feed3c5dc2a53ee2ee382a6c33</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature11183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11183%26sid%3Dliteratum%253Aachs%26aulast%3DStraussman%26aufirst%3DR.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DBarzily-Rokni%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DZ.%2BR.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DMongare%26aufirst%3DM.%2BM.%26aulast%3DGould%26aufirst%3DJ.%26aulast%3DFrederick%26aufirst%3DD.%2BT.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DLo%26aufirst%3DR.%2BS.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DOgino%26aufirst%3DS.%26aulast%3DWargo%26aufirst%3DJ.%2BA.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DTumour%2520micro-environment%2520elicits%2520innate%2520resistance%2520to%2520RAF%2520inhibitors%2520through%2520HGF%2520secretion%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D500%26epage%3D504%26doi%3D10.1038%2Fnature11183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marando, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behshad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span> </span><span class="NLM_article-title">A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7127</span><span class="NLM_x">–</span> <span class="NLM_lpage">7138</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1078-0432.CCR-11-1157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21918175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7127-7138&author=X.+Liuauthor=Q.+Wangauthor=G.+Yangauthor=C.+Marandoauthor=H.+K.+Koblishauthor=L.+M.+Hallauthor=J.+S.+Fridmanauthor=E.+Behshadauthor=R.+Wynnauthor=Y.+Liauthor=J.+Boerauthor=S.+Diamondauthor=C.+Heauthor=M.+Xuauthor=J.+Zhuoauthor=W.+Yaoauthor=R.+C.+Newtonauthor=P.+A.+Scherle&title=A+novel+kinase+inhibitor%2C+INCB28060%2C+blocks+c-MET-dependent+signaling%2C+neoplastic+activities%2C+and+cross-talk+with+EGFR+and+HER-3&doi=10.1158%2F1078-0432.CCR-11-1157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3</span></div><div class="casAuthors">Liu, Xiangdong; Wang, Qian; Yang, Gengjie; Marando, Cindy; Koblish, Holly K.; Hall, Leslie M.; Fridman, Jordan S.; Behshad, Elham; Wynn, Richard; Li, Yu; Boer, Jason; Diamond, Sharon; He, Chunhong; Xu, Meizhong; Zhuo, Jincong; Yao, Wenqing; Newton, Robert C.; Scherle, Peggy A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7127-7138</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The c-MET receptor tyrosine kinase plays important roles in the formation, progression, and dissemination of human cancer and presents an attractive therapeutic target.  This study describes the preclin. characterization of INCB28060, a novel inhibitor of c-MET kinase.  Exptl. Design: Studies were conducted using a series of in vitro and in vivo biochem. and biol. expts.  RESULTS: INCB28060 exhibits picomolar enzymic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases.  This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.  As a result, INCB28060 potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis in vitro.  Oral dosing of INCB28060 results in time- and dose-dependent inhibition of c-MET phosphorylation and tumor growth in c-MET-driven mouse tumor models, and the inhibitor is well tolerated at doses that achieve complete tumor inhibition.  In a further exploration of potential interactions between c-MET and other signaling pathways, we found that activated c-MET pos. regulates the activity of epidermal growth factor receptors (EGFR) and HER-3, as well as expression of their ligands.  These effects are reversed with INCB28060 treatment.  Finally, we confirmed that circulating hepatocyte growth factor levels are significantly elevated in patients with various cancers.  CONCLUSIONS: Activated c-MET has pleiotropic effects on multiple cancer-promoting signaling pathways and may play a crit. role in driving tumor cell growth and survival.  INCB28060 is a potent and selective c-MET kinase inhibitor that may have therapeutic potential in cancer treatment.  Clin Cancer Res; 17(22); 7127-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqT6dM1mGprVg90H21EOLACvtfcHk0liIxfmtxFl9dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK&md5=c272514704702cb5cbcc9e405bea3c53</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1157%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DMarando%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DHall%26aufirst%3DL.%2BM.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBehshad%26aufirst%3DE.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520kinase%2520inhibitor%252C%2520INCB28060%252C%2520blocks%2520c-MET-dependent%2520signaling%252C%2520neoplastic%2520activities%252C%2520and%2520cross-talk%2520with%2520EGFR%2520and%2520HER-3%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D7127%26epage%3D7138%26doi%3D10.1158%2F1078-0432.CCR-11-1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bladt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friese-Hamim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuehl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fittschen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyring, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaehrling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehl, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaukat, A.</span><span> </span><span class="NLM_article-title">EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2941</span><span class="NLM_x">–</span> <span class="NLM_lpage">2951</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1078-0432.CCR-12-3247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=23553846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos12ju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2941-2951&author=F.+Bladtauthor=B.+Fadenauthor=M.+Friese-Hamimauthor=C.+Knuehlauthor=C.+Wilmauthor=C.+Fittschenauthor=U.+Gradlerauthor=M.+Meyringauthor=D.+Dorschauthor=F.+Jaehrlingauthor=U.+Pehlauthor=F.+Stieberauthor=O.+Schadtauthor=A.+Blaukat&title=EMD+1214063+and+EMD+1204831+constitute+a+new+class+of+potent+and+highly+selective+c-Met+inhibitors&doi=10.1158%2F1078-0432.CCR-12-3247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors</span></div><div class="casAuthors">Bladt, Friedhelm; Faden, Bettina; Friese-Hamim, Manja; Knuehl, Christine; Wilm, Claudia; Fittschen, Claus; Graedler, Ulrich; Meyring, Michael; Dorsch, Dieter; Jaehrling, Frank; Pehl, Ulrich; Stieber, Frank; Schadt, Oliver; Blaukat, Andree</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2941-2951</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The mesenchymal-epithelial transition factor (c-Met) receptor, also known as hepatocyte growth factor receptor (HGFR), controls morphogenesis, a process that is physiol. required for embryonic development and tissue repair.  Aberrant c-Met activation is assocd. with a variety of human malignancies including cancers of the lung, kidney, stomach, liver, and brain.  In this study, we investigated the properties of two novel compds. developed to selectively inhibit the c-Met receptor in antitumor therapeutic interventions.  Exptl. Design: The pharmacol. properties, c-Met inhibitory activity, and antitumor effects of EMD 1214063 and EMD 1204831 were investigated in vitro and in vivo, using human cancer cell lines and mouse xenograft models.  Results: EMD 1214063 and EMD 1204831 selectively suppressed the c-Met receptor tyrosine kinase activity.  Their inhibitory activity was potent [inhibitory 50% concn. (IC50), 3 nmol/L and 9 nmol/L, resp.] and highly selective, when compared with their effect on a panel of 242 human kinases.  Both EMD 1214063 and EMD 1204831 inhibited c-Met phosphorylation and downstream signaling in a dose-dependent fashion, but differed in the duration of their inhibitory activity.  In murine xenograft models, both compds. induced regression of human tumors, regardless of whether c-Met activation was HGF dependent or independent.  Both drugs were well tolerated and induced no substantial wt. loss after more than 3 wk of treatment.  Conclusions: Our results indicate selective c-Met inhibition by EMD 1214063 and EMD 1204831 and strongly support clin. testing of these compds. in the context of molecularly targeted anticancer strategies.  Clin Cancer Res; 19(11); 2941-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2ZWzE5rC6LVg90H21EOLACvtfcHk0liIxfmtxFl9dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos12ju78%253D&md5=a1d24bf9fdaea35808c7468a6e7d197f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3247%26sid%3Dliteratum%253Aachs%26aulast%3DBladt%26aufirst%3DF.%26aulast%3DFaden%26aufirst%3DB.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DKnuehl%26aufirst%3DC.%26aulast%3DWilm%26aufirst%3DC.%26aulast%3DFittschen%26aufirst%3DC.%26aulast%3DGradler%26aufirst%3DU.%26aulast%3DMeyring%26aufirst%3DM.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DJaehrling%26aufirst%3DF.%26aulast%3DPehl%26aufirst%3DU.%26aulast%3DStieber%26aufirst%3DF.%26aulast%3DSchadt%26aufirst%3DO.%26aulast%3DBlaukat%26aufirst%3DA.%26atitle%3DEMD%25201214063%2520and%2520EMD%25201204831%2520constitute%2520a%2520new%2520class%2520of%2520potent%2520and%2520highly%2520selective%2520c-Met%2520inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D2941%26epage%3D2951%26doi%3D10.1158%2F1078-0432.CCR-12-3247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, W.</span><span> </span><span class="NLM_article-title">Discovery of (S)-1-(1-(imidazo[1,2- a ]pyridin-6-yl)ethyl)-6-(1-methyl-1 H -pyrazol-4-yl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7577</span><span class="NLM_x">–</span> <span class="NLM_lpage">7589</span><span class="refDoi"> DOI: 10.1021/jm500510f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500510f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7577-7589&author=H.+Jiaauthor=G.+Daiauthor=J.+Wengauthor=Z.+Zhangauthor=Q.+Wangauthor=F.+Zhouauthor=L.+Jiaoauthor=Y.+Cuiauthor=Y.+Renauthor=S.+Fanauthor=J.+Zhouauthor=W.+Qingauthor=Y.+Guauthor=J.+Wangauthor=Y.+Saiauthor=W.+Su&title=Discovery+of+%28S%29-1-%281-%28imidazo%5B1%2C2-+a+%5Dpyridin-6-yl%29ethyl%29-6-%281-methyl-1+H+-pyrazol-4-yl%29-1+H+-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-+b+%5Dpyrazine+%28volitinib%29+as+a+highly+potent+and+selective+mesenchymal-epithelial+transition+factor+%28c-Met%29+inhibitor+in+clinical+development+for+treatment+of+cancer&doi=10.1021%2Fjm500510f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm500510f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500510f%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%2528imidazo%255B1%252C2-%2520a%2520%255Dpyridin-6-yl%2529ethyl%2529-6-%25281-methyl-1%2520H%2520-pyrazol-4-yl%2529-1%2520H%2520-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-%2520b%2520%255Dpyrazine%2520%2528volitinib%2529%2520as%2520a%2520highly%2520potent%2520and%2520selective%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-Met%2529%2520inhibitor%2520in%2520clinical%2520development%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7577%26epage%3D7589%26doi%3D10.1021%2Fjm500510f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hughes, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caenepeel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">19 Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">728</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1538-7445.AM2014-728" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=728&issue=19+Suppl.&author=P.+E.+Hughesauthor=Y.+Yangauthor=K.+Rexauthor=Y.+Zhangauthor=P.+J.+Kaplan-Lefkoauthor=S.+Caenepeelauthor=J.+Moriguchiauthor=M.+Broomeauthor=D.+Choquetteauthor=R.+Radinskyauthor=R.+Kendallauthor=A.+Coxonauthor=I.+Dussault&title=AMG+337%2C+a+novel%2C+potent+and+selective+MET+kinase+inhibitor%2C+has+robust+growth+inhibitory+activity+in+MET-dependent+cancer+models&doi=10.1158%2F1538-7445.AM2014-728"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-728%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DP.%2BE.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DCaenepeel%26aufirst%3DS.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DBroome%26aufirst%3DM.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DRadinsky%26aufirst%3DR.%26aulast%3DKendall%26aufirst%3DR.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DAMG%2520337%252C%2520a%2520novel%252C%2520potent%2520and%2520selective%2520MET%2520kinase%2520inhibitor%252C%2520has%2520robust%2520growth%2520inhibitory%2520activity%2520in%2520MET-dependent%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D19%2520Suppl%26spage%3D728%26doi%3D10.1158%2F1538-7445.AM2014-728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Okamoto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span> </span><span class="NLM_article-title">Antitumor action of the MET tyrosine kinase inhibitor Crizotinib (PF-02341066) in gastric cancer positive for MET amplification</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1535-7163.MCT-11-0934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=22729845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1557-1564&author=W.+Okamotoauthor=I.+Okamotoauthor=T.+Araoauthor=K.+Kuwataauthor=H.+Yamaguchiauthor=K.+Sakaiauthor=K.+Yanagiharaauthor=K.+Nishioauthor=K.+Nakagawa&title=Antitumor+action+of+the+MET+tyrosine+kinase+inhibitor+Crizotinib+%28PF-02341066%29+in+gastric+cancer+positive+for+MET+amplification&doi=10.1158%2F1535-7163.MCT-11-0934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for MET Amplification</span></div><div class="casAuthors">Okamoto, Wataru; Okamoto, Isamu; Arao, Tokuzo; Kuwata, Kiyoko; Hatashita, Erina; Yamaguchi, Haruka; Sakai, Kazuko; Yanagihara, Kazuyoshi; Nishio, Kazuto; Nakagawa, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1557-1564</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Therapeutic strategies that target the tyrosine kinase MET hold promise for gastric cancer, but the mechanism underlying the antitumor activity of such strategies remains unclear.  We examd. the antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer cells pos. or neg. for MET amplification.  Inhibition of MET signaling by crizotinib or RNA interference-mediated MET depletion resulted in induction of apoptosis accompanied by inhibition of AKT and extracellular signal-regulated kinase phosphorylation in gastric cancer cells with MET amplification but not in those without it, suggesting that MET signaling is essential for the survival of MET amplification-pos. cells.  Crizotinib upregulated the expression of BIM, a proapoptotic member of the Bcl-2 family, as well as downregulated that of survivin, X-linked inhibitor of apoptosis protein (XIAP), and c-IAP1, members of the inhibitor of apoptosis protein family, in cells with MET amplification.  Forced depletion of BIM inhibited crizotinib-induced apoptosis, suggesting that upregulation of BIM contributes to the proapoptotic effect of crizotinib.  Crizotinib also exhibited a marked antitumor effect in gastric cancer xenografts pos. for MET amplification, whereas it had little effect on those neg. for this genetic change.  Crizotinib thus shows a marked antitumor action both in vitro and in vivo specifically in gastric cancer cells pos. for MET amplification.  Mol Cancer Ther; 11(7); 1557-64. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6365v7Z1HwbVg90H21EOLACvtfcHk0ljFU4W-j4a1jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKrtbc%253D&md5=fe2d495e894f32795eedcc8de80c7e14</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0934%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DW.%26aulast%3DOkamoto%26aufirst%3DI.%26aulast%3DArao%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DYanagihara%26aufirst%3DK.%26aulast%3DNishio%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DK.%26atitle%3DAntitumor%2520action%2520of%2520the%2520MET%2520tyrosine%2520kinase%2520inhibitor%2520Crizotinib%2520%2528PF-02341066%2529%2520in%2520gastric%2520cancer%2520positive%2520for%2520MET%2520amplification%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D1557%26epage%3D1564%26doi%3D10.1158%2F1535-7163.MCT-11-0934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemecek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wentzler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grapinet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khider, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dischamps, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnefraud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacqué, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenigsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span> </span><span class="NLM_article-title">SAR125844: a potent and selective ATP-competitive inhibitor of MET kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">8, Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">2911</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2012-2911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1538-7445.AM2012-2911" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2911&issue=8%2C+Suppl.+1&author=L.+Schioauthor=C.+Nemecekauthor=T.+Ugoliniauthor=S.+Wentzlerauthor=S.+Grapinetauthor=J.+Khiderauthor=E.+Albertauthor=N.+Dischampsauthor=F.+Gayauthor=V.+Sonnefraudauthor=E.+Bacqu%C3%A9author=M.+Kenigsbergauthor=H.+Goulaouicauthor=A.+Dagallierauthor=F.+Vall%C3%A9eauthor=F.+Boncheauthor=C.+Lengauer&title=SAR125844%3A+a+potent+and+selective+ATP-competitive+inhibitor+of+MET+kinase&doi=10.1158%2F1538-7445.AM2012-2911"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2012-2911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2012-2911%26sid%3Dliteratum%253Aachs%26aulast%3DSchio%26aufirst%3DL.%26aulast%3DNemecek%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DT.%26aulast%3DWentzler%26aufirst%3DS.%26aulast%3DGrapinet%26aufirst%3DS.%26aulast%3DKhider%26aufirst%3DJ.%26aulast%3DAlbert%26aufirst%3DE.%26aulast%3DDischamps%26aufirst%3DN.%26aulast%3DGay%26aufirst%3DF.%26aulast%3DSonnefraud%26aufirst%3DV.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26aulast%3DKenigsberg%26aufirst%3DM.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DDagallier%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DBonche%26aufirst%3DF.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DSAR125844%253A%2520a%2520potent%2520and%2520selective%2520ATP-competitive%2520inhibitor%2520of%2520MET%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D8%252C%2520Suppl.%25201%26spage%3D2911%26doi%3D10.1158%2F1538-7445.AM2012-2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Egile, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenigsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begassat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do-Vale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestadier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolas, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valence, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francesconi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemecek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span> </span><span class="NLM_article-title">The selective intravenous inhibitor of the MET tyrosine kinase SAR125844 inhibits tumor growth in MET-amplified cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1535-7163.MCT-14-0428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=25504634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlOjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=384-394&author=C.+Egileauthor=M.+Kenigsbergauthor=C.+Delaisiauthor=F.+Begassatauthor=V.+Do-Valeauthor=J.+Mestadierauthor=F.+Boncheauthor=T.+Benardauthor=J.+P.+Nicolasauthor=S.+Valenceauthor=C.+Lefrancauthor=E.+Francesconiauthor=C.+Castellauthor=A.+M.+Lefebvreauthor=C.+Nemecekauthor=L.+Calvetauthor=H.+Goulaouic&title=The+selective+intravenous+inhibitor+of+the+MET+tyrosine+kinase+SAR125844+inhibits+tumor+growth+in+MET-amplified+cancer&doi=10.1158%2F1535-7163.MCT-14-0428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in MET-Amplified Cancer</span></div><div class="casAuthors">Egile, Coumaran; Kenigsberg, Mireille; Delaisi, Christine; Begassat, Francoise; Do-Vale, Veronique; Mestadier, Jessica; Bonche, Fabrice; Benard, Tsiala; Nicolas, Jean-Paul; Valence, Sandrine; Lefranc, Celine; Francesconi, Elisa; Castell, Christelle; Lefebvre, Anne-Marie; Nemecek, Conception; Calvet, Loreley; Goulaouic, Helene</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-394</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of the MET/HGF pathway is common in human cancer and is thought to promote tumor initiation, metastasis, angiogenesis, and resistance to diverse therapies.  We report here the pharmacol. characterization of the triazolopyridazine deriv. SAR125844, a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK), for i.v. administration.  SAR125844 displayed nanomolar activity against the wild-type kinase (IC50 value of 4.2 nmol/L) and the M1250T and Y1235D mutants.  Broad biochem. profiling revealed that SAR125844 was highly selective for MET kinase.  SAR125844 inhibits MET autophosphorylation in cell-based assays in the nanomolar range, and promotes low nanomolar proapoptotic and antiproliferative activities selectively in cell lines with MET gene amplification or pathway addiction.  In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, i.v. treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.  Long duration of MET kinase inhibition up to 7 days was achieved with a nanosuspension formulation of SAR125844.  Daily or every-2-days i.v. treatment of SAR125844 promoted a dose-dependent tumor regression in MET-amplified human gastric cancer models at tolerated doses without treatment-related body wt. loss.  Our data demonstrated that SAR125844 is a potent and selective MET kinase inhibitor with a favorable preclin. toxicity profile, supporting its clin. development in patients with MET-amplified and MET pathway-addicted tumors.  Mol Cancer Ther; 14(2); 384-94. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphB-Rou5kYcLVg90H21EOLACvtfcHk0ljFU4W-j4a1jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlOjsb0%253D&md5=12a76fc417063f4b5d7cdc970f2ec605</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0428%26sid%3Dliteratum%253Aachs%26aulast%3DEgile%26aufirst%3DC.%26aulast%3DKenigsberg%26aufirst%3DM.%26aulast%3DDelaisi%26aufirst%3DC.%26aulast%3DBegassat%26aufirst%3DF.%26aulast%3DDo-Vale%26aufirst%3DV.%26aulast%3DMestadier%26aufirst%3DJ.%26aulast%3DBonche%26aufirst%3DF.%26aulast%3DBenard%26aufirst%3DT.%26aulast%3DNicolas%26aufirst%3DJ.%2BP.%26aulast%3DValence%26aufirst%3DS.%26aulast%3DLefranc%26aufirst%3DC.%26aulast%3DFrancesconi%26aufirst%3DE.%26aulast%3DCastell%26aufirst%3DC.%26aulast%3DLefebvre%26aufirst%3DA.%2BM.%26aulast%3DNemecek%26aufirst%3DC.%26aulast%3DCalvet%26aufirst%3DL.%26aulast%3DGoulaouic%26aufirst%3DH.%26atitle%3DThe%2520selective%2520intravenous%2520inhibitor%2520of%2520the%2520MET%2520tyrosine%2520kinase%2520SAR125844%2520inhibits%2520tumor%2520growth%2520in%2520MET-amplified%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D384%26epage%3D394%26doi%3D10.1158%2F1535-7163.MCT-14-0428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span><span class="refDoi"> DOI: 10.1021/cb500129t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500129t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1230-1241&author=Z.+Zhaoauthor=H.+Wuauthor=L.+Wangauthor=Y.+Liuauthor=S.+Knappauthor=Q.+Liuauthor=N.+S.+Gray&title=Exploration+of+type+II+binding+mode%3A+a+privileged+approach+for+kinase+inhibitor+focused+drug+discovery&doi=10.1021%2Fcb500129t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500129t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520of%2520type%2520II%2520binding%2520mode%253A%2520a%2520privileged%2520approach%2520for%2520kinase%2520inhibitor%2520focused%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1230%26epage%3D1241%26doi%3D10.1021%2Fcb500129t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M-H.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaida, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span> </span><span class="NLM_article-title">Discovery of (R)-6-(1-(8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-ethoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a potent and selective inhibitor of MET with high unbound target coverage and robust in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2328</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2328-2342&issue=6&author=A.+A.+Boezioauthor=K.+W.+Copelandauthor=K.+Rexauthor=B.+K.+Albrechtauthor=D.+Bauerauthor=S.+F.+Bellonauthor=C.+Boezioauthor=M.+A.+Broomeauthor=D.+Choquetteauthor=A.+Coxonauthor=I.+Dussaultauthor=S.+Hiraiauthor=R.+Lewisauthor=M-H.J.+Linauthor=J.+Lohmanauthor=J.+Liuauthor=E.+A.+Petersonauthor=M.+Potashmanauthor=R.+Shimanovichauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=K.+R.+Vaidaauthor=J.-C.+Harmange&title=Discovery+of+%28R%29-6-%281-%288-fluoro-6-%281-methyl-1H-pyrazol-4-yl%29-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridin-3-yl%29ethyl%29-3-%282-ethoxyethoxy%29-1%2C6-naphthyridin-5%286H%29-one+%28AMG+337%29%2C+a+potent+and+selective+inhibitor+of+MET+with+high+unbound+target+coverage+and+robust+in+vivo+antitumor+activity&doi=10.1021%2Facs.jmedchem.5b01716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01716%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DBroome%26aufirst%3DM.%2BA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DM-H.J.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-%25281-%25288-fluoro-6-%25281-methyl-1H-pyrazol-4-yl%2529-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529ethyl%2529-3-%25282-ethoxyethoxy%2529-1%252C6-naphthyridin-5%25286H%2529-one%2520%2528AMG%2520337%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520MET%2520with%2520high%2520unbound%2520target%2520coverage%2520and%2520robust%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2328%26epage%3D2342%26doi%3D10.1021%2Facs.jmedchem.5b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lolkema, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohets, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkenau, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Doorn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellemans, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskens, F. A.</span><span> </span><span class="NLM_article-title">The c-Met tyrosine kinase inhibitor JNJ-38877605 causes renal toxicity through species-specific insoluble metabolite formation</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1078-0432.CCR-14-3258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=25745036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2297-304&issue=10&author=M.+P.+Lolkemaauthor=H.+H.+Bohetsauthor=H.+T.+Arkenauauthor=A.+Lampoauthor=E.+Baraleauthor=M.+J.+de+Jongeauthor=L.+van+Doornauthor=P.+Hellemansauthor=J.+S.+de+Bonoauthor=F.+A.+Eskens&title=The+c-Met+tyrosine+kinase+inhibitor+JNJ-38877605+causes+renal+toxicity+through+species-specific+insoluble+metabolite+formation&doi=10.1158%2F1078-0432.CCR-14-3258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation</span></div><div class="casAuthors">Lolkema, Martijn P.; Bohets, Hilde H.; Arkenau, Hendrik-Tobias; Lampo, Ann; Barale, Erio; de Jonge, Maja J. A.; van Doorn, Leni; Hellemans, Peter; de Bono, Johann S.; Eskens, Ferry A. L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2297-2304</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The receptor tyrosine kinase c-Met plays an important role in tumorigenesis and is a novel target for anticancer treatment.  This phase I, first-in-human trial, explored safety, pharmacokinetics, pharmacodynamics, and initial antitumor activity of JNJ-38877605, a potent and selective c-Met inhibitor.  Exptl. Design: We performed a phase I dose-escalation study according to the std. 3+3 design.  Results: Even at subtherapeutic doses, mild though recurrent renal toxicity was obsd. in virtually all patients.  Renal toxicity had not been obsd. in preclin. studies in rats and dogs.  Addnl. preclin. studies pointed toward the rabbit as a suitable toxicol. model, as the formation of the M10 metabolite of JNJ-38877605 specifically occurred in rabbits and humans.  Addnl. toxicol. studies in rabbits clearly demonstrated that JNJ-38877605 induced species-specific renal toxicity.  Histopathol. evaluation in rabbits revealed renal crystal formation with degenerative and inflammatory changes.  Identification of the components of these renal crystals revealed M1/3 and M5/6 metabolites.  Accordingly, it was found that humans and rabbits showed significantly increased systemic exposure to these metabolites relative to other species.  These main culprit insol. metabolites were generated by aldehyde oxidase activity.  Alternative dosing schedules of JNJ-3877605 and concomitant probenecid administration in rabbits failed to prevent renal toxicity at dose levels that could be pharmacol. active.  Conclusions: Combined clin. and correlative preclin. studies suggest that renal toxicity of JNJ-38877605 is caused by the formation of species-specific insol. metabolites.  These observations preclude further clin. development of JNJ-38877605.  Clin Cancer Res; 21(10); 2297-304. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro1cpkCcM_IbVg90H21EOLACvtfcHk0lh9BL_XxDPWyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D&md5=9900b077fbb0766d9c26b3908e7ee1c4</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3258%26sid%3Dliteratum%253Aachs%26aulast%3DLolkema%26aufirst%3DM.%2BP.%26aulast%3DBohets%26aufirst%3DH.%2BH.%26aulast%3DArkenau%26aufirst%3DH.%2BT.%26aulast%3DLampo%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DE.%26aulast%3Dde%2BJonge%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2BDoorn%26aufirst%3DL.%26aulast%3DHellemans%26aufirst%3DP.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DEskens%26aufirst%3DF.%2BA.%26atitle%3DThe%2520c-Met%2520tyrosine%2520kinase%2520inhibitor%2520JNJ-38877605%2520causes%2520renal%2520toxicity%2520through%2520species-specific%2520insoluble%2520metabolite%2520formation%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D10%26spage%3D2297%26epage%3D304%26doi%3D10.1158%2F1078-0432.CCR-14-3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounaud, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felce, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froning, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterman, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubol, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessert, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauder, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwinn, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emtage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burley, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, S. H.</span><span> </span><span class="NLM_article-title">SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3181</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1535-7163.MCT-09-0477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=19934279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3181-90&issue=12&author=S.+G.+Buchananauthor=J.+Hendleauthor=P.+S.+Leeauthor=C.+R.+Smithauthor=P.+Y.+Bounaudauthor=K.+A.+Jessenauthor=C.+M.+Tangauthor=N.+H.+Huserauthor=J.+D.+Felceauthor=K.+J.+Froningauthor=M.+C.+Petermanauthor=B.+E.+Aubolauthor=S.+F.+Gessertauthor=J.+M.+Sauderauthor=K.+D.+Schwinnauthor=M.+Russellauthor=I.+A.+Rooneyauthor=J.+Adamsauthor=B.+C.+Leonauthor=T.+H.+Doauthor=J.+M.+Blaneyauthor=P.+A.+Sprengelerauthor=D.+A.+Thompsonauthor=L.+Smythauthor=L.+A.+Pelletierauthor=S.+Atwellauthor=K.+Holmeauthor=S.+R.+Wassermanauthor=S.+Emtageauthor=S.+K.+Burleyauthor=S.+H.+Reich&title=SGX523+is+an+exquisitely+selective%2C+ATP-competitive+inhibitor+of+the+MET+receptor+tyrosine+kinase+with+antitumor+activity+in+vivo&doi=10.1158%2F1535-7163.MCT-09-0477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo</span></div><div class="casAuthors">Buchanan, Sean G.; Hendle, Jorg; Lee, Patrick S.; Smith, Christopher R.; Bounaud, Pierre-Yves; Jessen, Katti A.; Tang, Crystal M.; Huser, Nanni H.; Felce, Jeremy D.; Froning, Karen J.; Peterman, Marshall C.; Aubol, Brandon E.; Gessert, Steve F.; Sauder, J. Michael; Schwinn, Kenneth D.; Russell, Marijane; Rooney, Isabelle A.; Adams, Jason; Leon, Barbara C.; Do, Tuan H.; Blaney, Jeff M.; Sprengeler, Paul A.; Thompson, Devon A.; Smyth, Lydia; Pelletier, Laura A.; Atwell, Shane; Holme, Kevin; Wasserman, Stephen R.; Emtage, Spencer; Burley, Stephen K.; Reich, Siegfried H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3181-3190</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The MET receptor tyrosine kinase has emerged as an important target for the development of novel cancer therapeutics.  Activation of MET by mutation or gene amplification has been linked to kidney, gastric, and lung cancers.  In other cancers, such as glioblastoma, autocrine activation of MET has been demonstrated.  Several classes of ATP-competitive inhibitor have been described, which inhibit MET but also other kinases.  Here, we describe SGX523, a novel, ATP-competitive kinase inhibitor remarkable for its exquisite selectivity for MET.  SGX523 potently inhibited MET with an IC50 of 4 nmol/L and is >1000-fold selective vs. the >200-fold selectivity of other protein kinases tested in biochem. assays.  Crystallog. study revealed that SGX523 stabilizes MET in a unique inactive conformation that is inaccessible to other protein kinases, suggesting an explanation for the selectivity.  SGX523 inhibited MET-mediated signaling, cell proliferation, and cell migration at nanomolar concns. but had no effect on signaling dependent on other protein kinases, including the closely related RON, even at micromolar concns.  SGX523 inhibition of MET in vivo was assocd. with the dose-dependent inhibition of growth of tumor xenografts derived from human glioblastoma and lung and gastric cancers, confirming the dependence of these tumors on MET catalytic activity.  Our results show that SGX523 is the most selective inhibitor of MET catalytic activity described to date and is thus a useful tool to investigate the role of MET kinase in cancer without the confounding effects of promiscuous protein kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplt9w6z--VQ7Vg90H21EOLACvtfcHk0li1IiBCip2liA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbzI&md5=7410ae811f0bf2d3298691ed34d35878</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0477%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DBounaud%26aufirst%3DP.%2BY.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DTang%26aufirst%3DC.%2BM.%26aulast%3DHuser%26aufirst%3DN.%2BH.%26aulast%3DFelce%26aufirst%3DJ.%2BD.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DPeterman%26aufirst%3DM.%2BC.%26aulast%3DAubol%26aufirst%3DB.%2BE.%26aulast%3DGessert%26aufirst%3DS.%2BF.%26aulast%3DSauder%26aufirst%3DJ.%2BM.%26aulast%3DSchwinn%26aufirst%3DK.%2BD.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DRooney%26aufirst%3DI.%2BA.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DDo%26aufirst%3DT.%2BH.%26aulast%3DBlaney%26aufirst%3DJ.%2BM.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DSmyth%26aufirst%3DL.%26aulast%3DPelletier%26aufirst%3DL.%2BA.%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DHolme%26aufirst%3DK.%26aulast%3DWasserman%26aufirst%3DS.%2BR.%26aulast%3DEmtage%26aufirst%3DS.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DSGX523%2520is%2520an%2520exquisitely%2520selective%252C%2520ATP-competitive%2520inhibitor%2520of%2520the%2520MET%2520receptor%2520tyrosine%2520kinase%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D12%26spage%3D3181%26epage%3D90%26doi%3D10.1158%2F1535-7163.MCT-09-0477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kawasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Finding a better path to drug selectivity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span><span class="refDoi"> DOI: 10.1016/j.drudis.2011.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1016%2Fj.drudis.2011.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21839183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=985-990&author=Y.+Kawasakiauthor=E.+Freire&title=Finding+a+better+path+to+drug+selectivity&doi=10.1016%2Fj.drudis.2011.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a better path to drug selectivity</span></div><div class="casAuthors">Kawasaki, Yuko; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">985-990</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Extremely high affinity and selectivity are two of the most sought-after properties of drug mols.  Selectivity has been difficult to achieve, esp. for targets that belong to large families of structurally and functionally related proteins.  There are essentially two ways by which selectivity can be improved during lead optimization: a chem. modification of the lead compd. that improves the affinity towards the target to a higher extent than to off-target mols.; and a chem. modification that lowers the affinity of the lead compd. towards off-target mols.  Maximal selectivity is achieved when both mechanisms can be combined synergistically.  As we discuss here, anal. of several protease inhibitors that vary in a single functionality indicates that nonpolar functionalities preferentially follow the first mechanism, whereas polar functionalities follow the second, and that those features are imprinted in their thermodn. signatures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGj1IsjIk4bbVg90H21EOLACvtfcHk0li1IiBCip2liA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF&md5=68ab56fd05adcdc61d12ee955b0fddc5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DFinding%2520a%2520better%2520path%2520to%2520drug%2520selectivity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D985%26epage%3D990%26doi%3D10.1016%2Fj.drudis.2011.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0li1IiBCip2liA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F. T.</span><span> </span><span class="NLM_article-title">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17783</span><span class="NLM_x">–</span> <span class="NLM_lpage">17788</span><span class="refDoi"> DOI: 10.1073/pnas.0607656103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0607656103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=17095602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17783-17788&author=A.+P.+Kornevauthor=N.+M.+Hasteauthor=S.+S.+Taylorauthor=L.+F.+T.+Ten+Eyck&title=Surface+comparison+of+active+and+inactive+protein+kinases+identifies+a+conserved+activation+mechanism&doi=10.1073%2Fpnas.0607656103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span></div><div class="casAuthors">Kornev, Alexandr P.; Haste, Nina M.; Taylor, Susan S.; Ten Eyck, Lynn F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17783-17788</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The surface comparison of different serine-threonine and tyrosine kinases reveals a set of 30 residues whose spatial positions are highly conserved.  The comparison between active and inactive conformations identified the residues whose positions are the most sensitive to activation.  Based on these results, we propose a model of protein kinase activation.  This model explains how the presence of a phosphate group in the activation loop dets. the position of the catalytically important aspartate in the Asp-Phe-Gly (DFG) motif.  According to the model, the most important feature of the activation is a "spine" formation that is dynamically assembled in all active kinases.  The spine is comprised of four hydrophobic residues that we detected in a set of 23 eukaryotic and prokaryotic kinases.  It spans the mol. and plays a coordinating role in activated kinases.  The spine is disordered in the inactive kinases and can explain how stabilization of the whole mol. is achieved upon phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwv4ByA5owH7Vg90H21EOLACvtfcHk0li-kDHUev_5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ&md5=f474acffd8b17d8352ac9f6fc9bbbf8f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0607656103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0607656103%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%2BT.%26atitle%3DSurface%2520comparison%2520of%2520active%2520and%2520inactive%2520protein%2520kinases%2520identifies%2520a%2520conserved%2520activation%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D17783%26epage%3D17788%26doi%3D10.1073%2Fpnas.0607656103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Albert, E.; Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S.</span><span> </span><span class="NLM_article-title">Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as MET inhibitors</span>. WO2009056692 A2; May 7,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Albert&author=E.+Bacque&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Novel+6-triazolopyridazinesulfanyl+benzothiazole+and+benzimidazole+derivatives%2C+method+for+production+thereof+and+application+as+medicaments+and+pharmaceutical+compositions+and+novel+use+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DE.%26atitle%3DNovel%25206-triazolopyridazinesulfanyl%2520benzothiazole%2520and%2520benzimidazole%2520derivatives%252C%2520method%2520for%2520production%2520thereof%2520and%2520application%2520as%2520medicaments%2520and%2520pharmaceutical%2520compositions%2520and%2520novel%2520use%2520as%2520MET%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span> </span><span class="NLM_article-title">Molecular property design: does everyone get it?</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=722-725&author=P.+D.+Leesonauthor=R.+J.+Young&title=Molecular+property+design%3A+does+everyone+get+it%3F&doi=10.1021%2Facsmedchemlett.5b00157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Property Design: Does Everyone Get It?</span></div><div class="casAuthors">Leeson, Paul D.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">722-725</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The principles of mol. property optimization in drug design have been understood for decades, yet much drug discovery activity today is conducted at the periphery of historical druglike property space.  Lead optimization trajectories aimed at reducing physicochem. risk, assisted by ligand efficiency metrics, could help to reduce clin. attrition rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_t8gIn79arVg90H21EOLACvtfcHk0li-kDHUev_5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D&md5=5a807a8d049ce8cf4adc186891a9234d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00157%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMolecular%2520property%2520design%253A%2520does%2520everyone%2520get%2520it%253F%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D722%26epage%3D725%26doi%3D10.1021%2Facsmedchemlett.5b00157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0li-kDHUev_5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Doak, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobritzsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span> </span><span class="NLM_article-title">How beyond rule of 5 drugs and clinical candidates bind to their targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2327</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2312-2327&issue=6&author=B.+C.+Doakauthor=J.+Zhengauthor=D.+Dobritzschauthor=J.+Kihlberg&title=How+beyond+rule+of+5+drugs+and+clinical+candidates+bind+to+their+targets&doi=10.1021%2Facs.jmedchem.5b01286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets</span></div><div class="casAuthors">Doak, Bradley C.; Zheng, Jie; Dobritzsch, Doreen; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve discovery of drugs for difficult targets, the opportunities of chem. space beyond the rule of 5 (bRo5) were examd. by retrospective anal. of a comprehensive set of structures for complexes between drugs and clin. candidates and their targets.  The anal. illustrates the potential of compds. far beyond rule of 5 space to modulate novel and difficult target classes that have large, flat, and groove-shaped binding sites.  However, ligand efficiencies are significantly reduced for flat- and groove-shape binding sites, suggesting that adjustments of how to use such metrics are required.  Ligands bRo5 appear to benefit from an appropriate balance between rigidity and flexibility to bind with sufficient affinity to their targets, with macrocycles and nonmacrocycles being found to have similar flexibility.  However, macrocycles were more disk- and spherelike, which may contribute to their superior binding to flat sites, while rigidification of nonmacrocycles lead to rodlike ligands that bind well to groove-shaped binding sites.  These insights should contribute to altering perceptions of what targets are considered "druggable" and provide support for drug design in beyond rule of 5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZD-h9VodiPLVg90H21EOLACvtfcHk0li-kDHUev_5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F&md5=a417b605d1a3ffbc7ee84706401f01f4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01286%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520beyond%2520rule%2520of%25205%2520drugs%2520and%2520clinical%2520candidates%2520bind%2520to%2520their%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2312%26epage%3D2327%26doi%3D10.1021%2Facs.jmedchem.5b01286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S.</span><span> </span><span class="NLM_article-title">Derivatives of 6-(6-O-cycloalkyl or 6-NH-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors</span>. WO2010089506 A1, Aug 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Bacque&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Derivatives+of+6-%286-O-cycloalkyl+or+6-NH-cycloalkyl-triazolopyridazine-sulfanyl%29+benzothiazoles+and+benzimidazoles%2C+preparation+thereof%2C+use+thereof+as+drugs%2C+and+use+thereof+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBacque%26aufirst%3DE.%26atitle%3DDerivatives%2520of%25206-%25286-O-cycloalkyl%2520or%25206-NH-cycloalkyl-triazolopyridazine-sulfanyl%2529%2520benzothiazoles%2520and%2520benzimidazoles%252C%2520preparation%2520thereof%252C%2520use%2520thereof%2520as%2520drugs%252C%2520and%2520use%2520thereof%2520as%2520MET%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nemecek, C.; Ugolini, A.; Wentzler, S.</span>. <span> </span><span class="NLM_article-title">Derivatives of 6-(6-O-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors</span>. WO2010089507 A1; Aug 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Derivatives+of+6-%286-O-substituted-triazolopyridazine-sulfanyl%29+benzothiazoles+and+benzimidazoles%2C+preparation+thereof%2C+use+thereof+as+drugs%2C+and+use+thereof+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNemecek%26aufirst%3DC.%26atitle%3DDerivatives%2520of%25206-%25286-O-substituted-triazolopyridazine-sulfanyl%2529%2520benzothiazoles%2520and%2520benzimidazoles%252C%2520preparation%2520thereof%252C%2520use%2520thereof%2520as%2520drugs%252C%2520and%2520use%2520thereof%2520as%2520MET%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span>. <span class="NLM_contrib-group">Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S.</span><span> </span><span class="NLM_article-title">Derivatives of 6-(6-NH-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors</span>. WO2010089508 A1, Aug 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Bacque&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Derivatives+of+6-%286-NH-substituted-triazolopyridazine-sulfanyl%29+benzothiazoles+and+benzimidazoles%2C+preparation+thereof%2C+use+thereof+as+drugs%2C+and+use+thereof+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBacque%26aufirst%3DE.%26atitle%3DDerivatives%2520of%25206-%25286-NH-substituted-triazolopyridazine-sulfanyl%2529%2520benzothiazoles%2520and%2520benzimidazoles%252C%2520preparation%2520thereof%252C%2520use%2520thereof%2520as%2520drugs%252C%2520and%2520use%2520thereof%2520as%2520MET%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Angevin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitaleri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollebecque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harnois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazuir, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assadourian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marinis, F.</span><span> </span><span class="NLM_article-title">A first-in-human (FIH) phase I study of SAR125844, a novel selective MET kinase inhibitor, in patients (pts) with advanced solid tumors: Dose escalation results</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">5 Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">2506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=2506&issue=5+Suppl.&author=E.+Angevinauthor=G.+Spitaleriauthor=A.+Hollebecqueauthor=T.+De+Pasauthor=J.+C.+Soriaauthor=M.+Harnoisauthor=F.+Mazuirauthor=S.+Assadourianauthor=F.+De+Marinis&title=A+first-in-human+%28FIH%29+phase+I+study+of+SAR125844%2C+a+novel+selective+MET+kinase+inhibitor%2C+in+patients+%28pts%29+with+advanced+solid+tumors%3A+Dose+escalation+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngevin%26aufirst%3DE.%26aulast%3DSpitaleri%26aufirst%3DG.%26aulast%3DHollebecque%26aufirst%3DA.%26aulast%3DDe%2BPas%26aufirst%3DT.%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26aulast%3DHarnois%26aufirst%3DM.%26aulast%3DMazuir%26aufirst%3DF.%26aulast%3DAssadourian%26aufirst%3DS.%26aulast%3DDe%2BMarinis%26aufirst%3DF.%26atitle%3DA%2520first-in-human%2520%2528FIH%2529%2520phase%2520I%2520study%2520of%2520SAR125844%252C%2520a%2520novel%2520selective%2520MET%2520kinase%2520inhibitor%252C%2520in%2520patients%2520%2528pts%2529%2520with%2520advanced%2520solid%2520tumors%253A%2520Dose%2520escalation%2520results%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26issue%3D5%2520Suppl%26spage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b','cit30c'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gavin W. Collie, Cheryl M. Koh, Daniel J. O’Neill, Christopher J. Stubbs, Puneet Khurana, Alice Eddershaw, Arjan Snijder, Fredrik Mauritzson, Louise Barlind, Ian L. Dale, Joseph Shaw, Christopher Phillips, Edward J. Hennessy, Tony Cheung, <span class="NLM_string-name hlFld-ContribAuthor">Ana J. Narvaez</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1322-1327. <a href="https://doi.org/10.1021/acsmedchemlett.9b00276" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00276%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252Band%252BMolecular%252BInsight%252Binto%252BResistance%252BMechanisms%252Bof%252BFirst%252BGeneration%252BcMET%252BInhibitors%26aulast%3DCollie%26aufirst%3DGavin%2BW.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21062019%26date%3D02082019%26date%3D17082019%26date%3D02082019%26volume%3D10%26issue%3D9%26spage%3D1322%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran  Singh</span>, <span class="hlFld-ContribAuthor ">Prerna  Turk</span>, <span class="hlFld-ContribAuthor ">Raj  Kamal</span>, <span class="hlFld-ContribAuthor ">Anita  Dhanda</span>. </span><span class="cited-content_cbyCitation_article-title">New Palladium(II) complexes of 2-arylidene-1-(4-methyl-6-phenyl-pyrimidin-2-yl)hydrazines: synthesis, spectroscopic characterization, biological evaluation and protein binding. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2021,</strong> <em>86 </em><a href="https://doi.org/10.1007/s13738-021-02272-2" title="DOI URL">https://doi.org/10.1007/s13738-021-02272-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-021-02272-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-021-02272-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DNew%252BPalladium%252528II%252529%252Bcomplexes%252Bof%252B2-arylidene-1-%2525284-methyl-6-phenyl-pyrimidin-2-yl%252529hydrazines%25253A%252Bsynthesis%25252C%252Bspectroscopic%252Bcharacterization%25252C%252Bbiological%252Bevaluation%252Band%252Bprotein%252Bbinding%26aulast%3DSingh%26aufirst%3DKiran%26date%3D2021%26date%3D2021%26volume%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuya  Takimoto</span>, <span class="hlFld-ContribAuthor ">Hideaki  Sasaki</span>, <span class="hlFld-ContribAuthor ">Hirohito  Tsue</span>, <span class="hlFld-ContribAuthor ">Hiroki  Takahashi</span>, <span class="hlFld-ContribAuthor ">Alexander D.  MacKerell</span>, <span class="hlFld-ContribAuthor ">Ayumi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Katsuya  Nakano</span>, <span class="hlFld-ContribAuthor ">Eori  Okazaki</span>, <span class="hlFld-ContribAuthor ">Tatsuki  Betsuyaku</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Tachibana</span>, <span class="hlFld-ContribAuthor ">Kazuhito  Hioki</span>, <span class="hlFld-ContribAuthor ">Ozge  Yoluk</span>, <span class="hlFld-ContribAuthor ">Sunhwan  Jo</span>. </span><span class="cited-content_cbyCitation_article-title">Simple Synthesis of a Heterocyclophane Exhibiting Anti‐c‐Met Activity by Acting as a Hatch Blocking Access to the Active Site**. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (5)
                                     , 1648-1654. <a href="https://doi.org/10.1002/chem.202001382" title="DOI URL">https://doi.org/10.1002/chem.202001382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202001382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202001382%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSimple%252BSynthesis%252Bof%252Ba%252BHeterocyclophane%252BExhibiting%252BAnti%2525E2%252580%252590c%2525E2%252580%252590Met%252BActivity%252Bby%252BActing%252Bas%252Ba%252BHatch%252BBlocking%252BAccess%252Bto%252Bthe%252BActive%252BSite%252A%252A%26aulast%3DTakimoto%26aufirst%3DTatsuya%26date%3D2021%26date%3D2020%26volume%3D27%26issue%3D5%26spage%3D1648%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang-Ping  Yao</span>, <span class="hlFld-ContribAuthor ">Xiang-Min  Tong</span>, <span class="hlFld-ContribAuthor ">Ming-Hai  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Medical Oncology</span><span> <strong>2021,</strong> <em>13 </em>, 175883592110069. <a href="https://doi.org/10.1177/17588359211006957" title="DOI URL">https://doi.org/10.1177/17588359211006957</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/17588359211006957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F17588359211006957%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Medical%2520Oncology%26atitle%3DOncogenic%252Bmechanism-based%252Bpharmaceutical%252Bvalidation%252Bof%252Btherapeutics%252Btargeting%252BMET%252Breceptor%252Btyrosine%252Bkinase%26aulast%3DYao%26aufirst%3DHang-Ping%26date%3D2021%26date%3D2021%26volume%3D13%26spage%3D175883592110069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshio  Fujino</span>, <span class="hlFld-ContribAuthor ">Kenichi  Suda</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Mitsudomi</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2020,</strong> <em>25 </em>
                                    (3)
                                     , 229-249. <a href="https://doi.org/10.1080/14728214.2020.1791821" title="DOI URL">https://doi.org/10.1080/14728214.2020.1791821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728214.2020.1791821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728214.2020.1791821%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DEmerging%252BMET%252Btyrosine%252Bkinase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DFujino%26aufirst%3DToshio%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D3%26spage%3D229%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Schio</span>, <span class="hlFld-ContribAuthor ">Herve  Minoux</span>. </span><span class="cited-content_cbyCitation_article-title">Achieving High Levels of Selectivity for Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 95-123. <a href="https://doi.org/10.1007/7355_2020_99" title="DOI URL">https://doi.org/10.1007/7355_2020_99</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_99%26sid%3Dliteratum%253Aachs%26atitle%3DAchieving%252BHigh%252BLevels%252Bof%252BSelectivity%252Bfor%252BKinase%252BInhibitors%26aulast%3DSchio%26aufirst%3DLaurent%26date%3D2020%26date%3D2020%26spage%3D95%26epage%3D123%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tahereh  Damghani</span>, <span class="hlFld-ContribAuthor ">Korosh  Mashayekh</span>, <span class="hlFld-ContribAuthor ">Somayeh  Pirhadi</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Shahrzad  Sharifi</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Mohammad Sadegh  Avestan</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of cytotoxic activity of a series of 1H-pyrrolo[2,3-b]pyridine derivatives as possible inhibitors of c-Met using molecular fingerprints. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2019,</strong> <em>39 </em>
                                    (4)
                                     , 295-303. <a href="https://doi.org/10.1080/10799893.2019.1676258" title="DOI URL">https://doi.org/10.1080/10799893.2019.1676258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2019.1676258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2019.1676258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DPrediction%252Bof%252Bcytotoxic%252Bactivity%252Bof%252Ba%252Bseries%252Bof%252B1H-pyrrolo%25255B2%25252C3-b%25255Dpyridine%252Bderivatives%252Bas%252Bpossible%252Binhibitors%252Bof%252Bc-Met%252Busing%252Bmolecular%252Bfingerprints%26aulast%3DDamghani%26aufirst%3DTahereh%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D4%26spage%3D295%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Wen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zi-Dan  Ye</span>, <span class="hlFld-ContribAuthor ">Chang  Shen</span>, <span class="hlFld-ContribAuthor ">Hong-Xia  Tie</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 124-133. <a href="https://doi.org/10.1080/14756366.2018.1533822" title="DOI URL">https://doi.org/10.1080/14756366.2018.1533822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1533822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1533822%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252B6%25252C7-dimethoxy-4-anilinoquinolines%252Bas%252Bpotent%252Bc-Met%252Binhibitors%26aulast%3DZhang%26aufirst%3DQing-Wen%26date%3D2019%26date%3D2018%26volume%3D34%26issue%3D1%26spage%3D124%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingmin  Ding</span>, <span class="hlFld-ContribAuthor ">Hongbo  Wang</span>, <span class="hlFld-ContribAuthor ">Chunrong  Qu</span>, <span class="hlFld-ContribAuthor ">Fuchun  Xu</span>, <span class="hlFld-ContribAuthor ">Yingmin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guangyao  Lv</span>, <span class="hlFld-ContribAuthor ">Yungang  Lu</span>, <span class="hlFld-ContribAuthor ">Qingjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Hui  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Zeng</span>, <span class="hlFld-ContribAuthor ">Jingwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunhong  Yan</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Lin</span>, <span class="hlFld-ContribAuthor ">Huai-Rong  Luo</span>, <span class="hlFld-ContribAuthor ">Zixing  Deng</span>, <span class="hlFld-ContribAuthor ">Yuling  Xiao</span>, <span class="hlFld-ContribAuthor ">Jinbin  Tian</span>, <span class="hlFld-ContribAuthor ">Michael X.  Zhu</span>, <span class="hlFld-ContribAuthor ">Xuechuan  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[1,5-a]pyrimidine TRPC6 antagonists for the treatment of gastric cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2018,</strong> <em>432 </em>, 47-55. <a href="https://doi.org/10.1016/j.canlet.2018.05.041" title="DOI URL">https://doi.org/10.1016/j.canlet.2018.05.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2018.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2018.05.041%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DPyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252BTRPC6%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bgastric%252Bcancer%26aulast%3DDing%26aufirst%3DMingmin%26date%3D2018%26volume%3D432%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oshin  Miranda</span>, <span class="hlFld-ContribAuthor ">Mariya  Farooqui</span>, <span class="hlFld-ContribAuthor ">Jill  Siegfried</span>. </span><span class="cited-content_cbyCitation_article-title">Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (9)
                                     , 280. <a href="https://doi.org/10.3390/cancers10090280" title="DOI URL">https://doi.org/10.3390/cancers10090280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10090280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10090280%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DStatus%252Bof%252BAgents%252BTargeting%252Bthe%252BHGF%25252Fc-Met%252BAxis%252Bin%252BLung%252BCancer%26aulast%3DMiranda%26aufirst%3DOshin%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D9%26spage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaobo  Liu</span>, <span class="hlFld-ContribAuthor ">Jianlan  Kou</span>, <span class="hlFld-ContribAuthor ">Zhen  Xiao</span>, <span class="hlFld-ContribAuthor ">Fajuan  Tian</span>, <span class="hlFld-ContribAuthor ">Jiayi  Hu</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1543. <a href="https://doi.org/10.3390/molecules23071543" title="DOI URL">https://doi.org/10.3390/molecules23071543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071543%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B6%25252C7-Disubstituted-4-phenoxyquinoline%252BDerivatives%252BBearing%252BPyridazinone%252BMoiety%252Bas%252Bc-Met%252BInhibitors%26aulast%3DLiu%26aufirst%3DXiaobo%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Libo  Yan</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Qiao</span>, <span class="hlFld-ContribAuthor ">Jing  Pan</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Bingren  Xiang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into the key features for ligand binding in Y1230 mutated c-Met kinase domain by molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (8)
                                     , 2015-2031. <a href="https://doi.org/10.1080/07391102.2017.1340852" title="DOI URL">https://doi.org/10.1080/07391102.2017.1340852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1340852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1340852%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DInsight%252Binto%252Bthe%252Bkey%252Bfeatures%252Bfor%252Bligand%252Bbinding%252Bin%252BY1230%252Bmutated%252Bc-Met%252Bkinase%252Bdomain%252Bby%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DYan%26aufirst%3DLibo%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D8%26spage%3D2015%26epage%3D2031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palak K.  Parikh</span>, <span class="hlFld-ContribAuthor ">Manjunath D.  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of small molecule c-Met Kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1103-1138. <a href="https://doi.org/10.1016/j.ejmech.2017.08.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252Bc-Met%252BKinase%252Binhibitors%26aulast%3DParikh%26aufirst%3DPalak%2BK.%26date%3D2018%26volume%3D143%26spage%3D1103%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Angevin</span>, <span class="hlFld-ContribAuthor ">Gianluca  Spitaleri</span>, <span class="hlFld-ContribAuthor ">Jordi  Rodon</span>, <span class="hlFld-ContribAuthor ">Katia  Dotti</span>, <span class="hlFld-ContribAuthor ">Nicolas  Isambert</span>, <span class="hlFld-ContribAuthor ">Stefania  Salvagni</span>, <span class="hlFld-ContribAuthor ">Victor  Moreno</span>, <span class="hlFld-ContribAuthor ">Sylvie  Assadourian</span>, <span class="hlFld-ContribAuthor ">Corinne  Gomez</span>, <span class="hlFld-ContribAuthor ">Marzia  Harnois</span>, <span class="hlFld-ContribAuthor ">Antoine  Hollebecque</span>, <span class="hlFld-ContribAuthor ">Analia  Azaro</span>, <span class="hlFld-ContribAuthor ">Alice  Hervieu</span>, <span class="hlFld-ContribAuthor ">Karim  Rihawi</span>, <span class="hlFld-ContribAuthor ">Filippo  De Marinis</span>. </span><span class="cited-content_cbyCitation_article-title">A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2017,</strong> <em>87 </em>, 131-139. <a href="https://doi.org/10.1016/j.ejca.2017.10.016" title="DOI URL">https://doi.org/10.1016/j.ejca.2017.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2017.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2017.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DA%252Bfirst-in-human%252Bphase%252BI%252Bstudy%252Bof%252BSAR125844%25252C%252Ba%252Bselective%252BMET%252Btyrosine%252Bkinase%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumours%252Bwith%252BMET%252Bamplification%26aulast%3DAngevin%26aufirst%3DEric%26date%3D2017%26volume%3D87%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational control in structure-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (13)
                                     , 2825-2837. <a href="https://doi.org/10.1016/j.bmcl.2017.04.079" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.079%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DConformational%252Bcontrol%252Bin%252Bstructure-based%252Bdrug%252Bdesign%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2825%26epage%3D2837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Alison Rinderspacher</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 441-482. <a href="https://doi.org/10.1016/B978-0-08-102310-5.00013-8" title="DOI URL">https://doi.org/10.1016/B978-0-08-102310-5.00013-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102310-5.00013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102310-5.00013-8%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DAlison%2BRinderspacher%26aufirst%3DK.%26date%3D2017%26spage%3D441%26epage%3D482%26pub%3DElsevier%26date%3D2017%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit and lead finding steps.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structures of WT MET with <b>3</b> (A) and of MET-Y1230H with <b>14</b> (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of key compounds with biochemical and ITC data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>12</b> in the Y1230H mutant showing the tight interaction with the hinge and the DFG Asp1222.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Unit cell and packing views in the X-ray single crystal diffraction structure of <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/medium/jm-2016-00280r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetic/pharmacodynamic (PK/PD) study of compound <b>12</b> in mice bearing xenograft tumor of the <i>MET</i>-amplified Hs 746T human gastric tumor cell line. Mice bearing established subcutaneous tumors derived from Hs 746T gastric cancer cell line were administered a single 20 mg/kg dose of <b>12</b> iv in the tail vein. The pharmacokinetic parameters of <b>12</b> were assessed by analysis of the drug concentrations in plasma and tumor tissue (A). The pharmacodynamic effect on MET kinase was assessed by analysis of phospho-MET(Y1349) levels in tumor extracts using Meso Scale Discovery (MSD) immunoassay (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00280/20160811/images/large/jm-2016-00280r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00280&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">MET signaling: principles and functions in development, organ regeneration and cancer</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/nrm3012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fnrm3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21102609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=834-848&author=L.+Trusolinoauthor=A.+Bertottiauthor=P.+M.+Comoglio&title=MET+signaling%3A+principles+and+functions+in+development%2C+organ+regeneration+and+cancer&doi=10.1038%2Fnrm3012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">MET signalling: principles and functions in development, organ regeneration and cancer</span></div><div class="casAuthors">Trusolino, Livio; Bertotti, Andrea; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">834-848</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The MET tyrosine kinase receptor (also known as the HGF receptor) promotes tissue remodelling, which underlies developmental morphogenesis, wound repair, organ homeostasis and cancer metastasis, by integrating growth, survival and migration cues in response to environmental stimuli or cell-autonomous perturbations.  The versatility of MET-mediated biol. responses is sustained by qual. and quant. signal modulation.  Qual. mechanisms include the engagement of dedicated signal transducers and the subcellular compartmentalization of MET signalling pathways, whereas quant. regulation involves MET partnering with adaptor amplifiers or being degraded through the shedding of its extracellular domain or through intracellular ubiquitylation.  Controlled activation of MET signalling can be exploited in regenerative medicine, whereas MET inhibition might slow down tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzaWXvEKEpVrVg90H21EOLACvtfcHk0lg5r818WXMvGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGrurfI&md5=c97f7b6ff2522bc0d20d0371d07c5ea2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3012%26sid%3Dliteratum%253Aachs%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DMET%2520signaling%253A%2520principles%2520and%2520functions%2520in%2520development%252C%2520organ%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D834%26epage%3D848%26doi%3D10.1038%2Fnrm3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G.</span><span> </span><span class="NLM_article-title">Targeting MET in cancer: rationale and progress</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1038/nrc3205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fnrc3205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=22270953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=89-103&author=E.+Gherardiauthor=W.+Birchmeierauthor=C.+Birchmeierauthor=G.+Vande+Woude&title=Targeting+MET+in+cancer%3A+rationale+and+progress&doi=10.1038%2Fnrc3205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MET in cancer: rationale and progress</span></div><div class="casAuthors">Gherardi, Ermanno; Birchmeier, Walter; Birchmeier, Carmen; Vande Woude, George</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-103</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of cancer.  Genetic and biochem. data have demonstrated that the growth and motility factor hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, the tyrosine kinase MET, have a causal role in all of these processes, thus providing a strong rationale for targeting these mols. in cancer.  Parallel progress in understanding the structure and function of HGF/SF, MET and assocd. signalling components has led to the successful development of blocking antibodies and a large no. of small-mol. MET kinase inhibitors.  In this Review, we discuss these advances, as well as results from recent clin. studies that demonstrate that inhibiting MET signalling in several types of solid human tumors has major therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6JxJEFNd5E7Vg90H21EOLACvtfcHk0lg5r818WXMvGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSmu7s%253D&md5=ea16195614f1dd385ed48fd29bad9a8d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc3205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3205%26sid%3Dliteratum%253Aachs%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DVande%2BWoude%26aufirst%3DG.%26atitle%3DTargeting%2520MET%2520in%2520cancer%253A%2520rationale%2520and%2520progress%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D89%26epage%3D103%26doi%3D10.1038%2Fnrc3205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bladt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riethmacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isenmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span><span class="refDoi"> DOI: 10.1038/376768a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2F376768a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=768-771&author=F.+Bladtauthor=D.+Riethmacherauthor=S.+Isenmannauthor=A.+Aguzziauthor=C.+Birchmeier&title=Essential+role+for+the+c-met+receptor+in+the+migration+of+myogenic+precursor+cells+into+the+limb+bud&doi=10.1038%2F376768a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F376768a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376768a0%26sid%3Dliteratum%253Aachs%26aulast%3DBladt%26aufirst%3DF.%26aulast%3DRiethmacher%26aufirst%3DD.%26aulast%3DIsenmann%26aufirst%3DS.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DEssential%2520role%2520for%2520the%2520c-met%2520receptor%2520in%2520the%2520migration%2520of%2520myogenic%2520precursor%2520cells%2520into%2520the%2520limb%2520bud%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D768%26epage%3D771%26doi%3D10.1038%2F376768a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Huh, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Factor, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, S. S.</span><span> </span><span class="NLM_article-title">Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">4477</span><span class="NLM_x">–</span> <span class="NLM_lpage">4482</span><span class="refDoi"> DOI: 10.1073/pnas.0306068101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0306068101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=4477-4482&issue=13&author=C.+G.+Huhauthor=V.+M.+Factorauthor=A.+S%C3%A1nchezauthor=K.+Uchidaauthor=E.+A.+Connerauthor=S.+S.+Thorgeirsson&title=Hepatocyte+growth+factor%2Fc-met+signaling+pathway+is+required+for+efficient+liver+regeneration+and+repair&doi=10.1073%2Fpnas.0306068101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0306068101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0306068101%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DC.%2BG.%26aulast%3DFactor%26aufirst%3DV.%2BM.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DConner%26aufirst%3DE.%2BA.%26aulast%3DThorgeirsson%26aufirst%3DS.%2BS.%26atitle%3DHepatocyte%2520growth%2520factor%252Fc-met%2520signaling%2520pathway%2520is%2520required%2520for%2520efficient%2520liver%2520regeneration%2520and%2520repair%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D13%26spage%3D4477%26epage%3D4482%26doi%3D10.1073%2Fpnas.0306068101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Borowiak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüstefeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trautwein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Met provides essential signals for liver regeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">10608</span><span class="NLM_x">–</span> <span class="NLM_lpage">10613</span><span class="refDoi"> DOI: 10.1073/pnas.0403412101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0403412101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10608-10613&issue=29&author=M.+Borowiakauthor=A.+N.+Garrattauthor=T.+W%C3%BCstefeldauthor=M.+Strehleauthor=C.+Trautweinauthor=C.+Birchmeier&title=Met+provides+essential+signals+for+liver+regeneration&doi=10.1073%2Fpnas.0403412101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0403412101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0403412101%26sid%3Dliteratum%253Aachs%26aulast%3DBorowiak%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DW%25C3%25BCstefeld%26aufirst%3DT.%26aulast%3DStrehle%26aufirst%3DM.%26aulast%3DTrautwein%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DMet%2520provides%2520essential%2520signals%2520for%2520liver%2520regeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D29%26spage%3D10608%26epage%3D10613%26doi%3D10.1073%2Fpnas.0403412101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Schmidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duh, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choyke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubensky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allikmets, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chidambaram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerheim, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltis, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamarron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernues, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lips, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orcutt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stackhouse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slife, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niehans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storkel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerman, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zbar, B.</span><span> </span><span class="NLM_article-title">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1038/ng0597-68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fng0597-68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=9140397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=68-73&issue=1&author=L.+Schmidtauthor=F.+M.+Duhauthor=F.+Chenauthor=T.+Kishidaauthor=G.+Glennauthor=P.+Choykeauthor=S.+W.+Schererauthor=Z.+Zhuangauthor=I.+Lubenskyauthor=M.+Deanauthor=R.+Allikmetsauthor=A.+Chidambaramauthor=U.+R.+Bergerheimauthor=J.+T.+Feltisauthor=C.+Casadevallauthor=A.+Zamarronauthor=M.+Bernuesauthor=S.+Richardauthor=C.+J.+Lipsauthor=M.+M.+Waltherauthor=L.+C.+Tsuiauthor=L.+Geilauthor=M.+L.+Orcuttauthor=T.+Stackhouseauthor=J.+Lipanauthor=L.+Slifeauthor=H.+Brauchauthor=J.+Deckerauthor=G.+Niehansauthor=M.+D.+Hughsonauthor=H.+Mochauthor=S.+Storkelauthor=M.+I.+Lermanauthor=W.+M.+Linehanauthor=B.+Zbar&title=Germline+and+somatic+mutations+in+the+tyrosine+kinase+domain+of+the+MET+proto-oncogene+in+papillary+renal+carcinomas&doi=10.1038%2Fng0597-68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas</span></div><div class="casAuthors">Schmidt, Laura; Duh, Fuh-Mei; Chen, Fan; Kishida, Takeshi; Glenn, Gladys; Choyke, Peter; Scherer, Stephen W.; Zhuang, Zhenping; Lubensky, Irina; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-73</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Hereditary papillary renal carcinoma (HPRC) is a recently recognized form of inherited kidney cancer characterized by a predisposition to develop multiple, bilateral papillary renal tumors.  The pattern of inheritance of HPRC is consistent with autosomal dominant transmission with reduced penetrance.  HPRC is histol. and genetically distinct from two other causes of inherited renal carcinoma, von Hippel-Lindau disease (VHL) and the chromosome translocation (3;8).  Malignant papillary renal carcinomas are characterized by trisomy of chromosomes 7, 16 and 17, and in men, by loss of the Y chromosome.  Inherited and sporadic clear cell renal carcinomas are characterized by inactivation of both copies of the VHL gene by mutation, and/or by hypermethylation.  We found that the HPRC gene was located at chromosome 7q31.1-34 in a 27-centimorgan (cM) interval between D7S496 and D7S1837.  We identified missense mutations located in the tyrosine kinase domain of the MET gene in the germline of affected members of HPRC families and in a subset of sporadic papillary renal carcinomas.  Three mutations in the MET gene are located in codons that are homologous to those in c-kit and RET, proto-oncogenes that are targets of naturally-occurring mutations.  The results suggest that missense mutations located in the MET proto-oncogene lead to constitutive activation of the MET protein and papillary renal carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-x_dqJPR-7Vg90H21EOLACvtfcHk0lhwedJVKkNgbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFKhsbw%253D&md5=7209dbbaa538b418defad117830df3c9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng0597-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0597-68%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DDuh%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DKishida%26aufirst%3DT.%26aulast%3DGlenn%26aufirst%3DG.%26aulast%3DChoyke%26aufirst%3DP.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DLubensky%26aufirst%3DI.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DAllikmets%26aufirst%3DR.%26aulast%3DChidambaram%26aufirst%3DA.%26aulast%3DBergerheim%26aufirst%3DU.%2BR.%26aulast%3DFeltis%26aufirst%3DJ.%2BT.%26aulast%3DCasadevall%26aufirst%3DC.%26aulast%3DZamarron%26aufirst%3DA.%26aulast%3DBernues%26aufirst%3DM.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DLips%26aufirst%3DC.%2BJ.%26aulast%3DWalther%26aufirst%3DM.%2BM.%26aulast%3DTsui%26aufirst%3DL.%2BC.%26aulast%3DGeil%26aufirst%3DL.%26aulast%3DOrcutt%26aufirst%3DM.%2BL.%26aulast%3DStackhouse%26aufirst%3DT.%26aulast%3DLipan%26aufirst%3DJ.%26aulast%3DSlife%26aufirst%3DL.%26aulast%3DBrauch%26aufirst%3DH.%26aulast%3DDecker%26aufirst%3DJ.%26aulast%3DNiehans%26aufirst%3DG.%26aulast%3DHughson%26aufirst%3DM.%2BD.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DStorkel%26aufirst%3DS.%26aulast%3DLerman%26aufirst%3DM.%2BI.%26aulast%3DLinehan%26aufirst%3DW.%2BM.%26aulast%3DZbar%26aufirst%3DB.%26atitle%3DGermline%2520and%2520somatic%2520mutations%2520in%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520MET%2520proto-oncogene%2520in%2520papillary%2520renal%2520carcinomas%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D16%26issue%3D1%26spage%3D68%26epage%3D73%26doi%3D10.1038%2Fng0597-68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kong-Beltran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshagiri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhawe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holcomb, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwall, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yauch, R.</span><span> </span><span class="NLM_article-title">Somatic mutations lead to an oncogenic deletion of Met in lung cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F0008-5472.CAN-05-2749" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=283-289&issue=1&author=M.+Kong-Beltranauthor=S.+Seshagiriauthor=J.+Zhaauthor=W.+Zhuauthor=K.+Bhaweauthor=N.+Mendozaauthor=T.+Holcombauthor=K.+Pujaraauthor=J.+Stinsonauthor=L.+Fuauthor=C.+Severinauthor=L.+Rangellauthor=R.+Schwallauthor=L.+Amlerauthor=D.+Wickramasingheauthor=R.+Yauch&title=Somatic+mutations+lead+to+an+oncogenic+deletion+of+Met+in+lung+cancer&doi=10.1158%2F0008-5472.CAN-05-2749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2749%26sid%3Dliteratum%253Aachs%26aulast%3DKong-Beltran%26aufirst%3DM.%26aulast%3DSeshagiri%26aufirst%3DS.%26aulast%3DZha%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DBhawe%26aufirst%3DK.%26aulast%3DMendoza%26aufirst%3DN.%26aulast%3DHolcomb%26aufirst%3DT.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSeverin%26aufirst%3DC.%26aulast%3DRangell%26aufirst%3DL.%26aulast%3DSchwall%26aufirst%3DR.%26aulast%3DAmler%26aufirst%3DL.%26aulast%3DWickramasinghe%26aufirst%3DD.%26aulast%3DYauch%26aufirst%3DR.%26atitle%3DSomatic%2520mutations%2520lead%2520to%2520an%2520oncogenic%2520deletion%2520of%2520Met%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D1%26spage%3D283%26epage%3D289%26doi%3D10.1158%2F0008-5472.CAN-05-2749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skokan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajapathy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felicioni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Grammastro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciarrotta, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttitta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incarbone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toschi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloisio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span> </span><span class="NLM_article-title">Increased MET gene copy number negatively affects survival of surgically resected non-small cell lung cancer patients</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span><span class="refDoi"> DOI: 10.1200/JCO.2008.19.1635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1200%2FJCO.2008.19.1635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=19255323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ktlKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1667-1674&issue=10&author=F.+Cappuzzoauthor=A.+Marchettiauthor=M.+Skokanauthor=E.+Rossiauthor=S.+Gajapathyauthor=L.+Felicioniauthor=M.+Del+Grammastroauthor=M.+G.+Sciarrottaauthor=F.+Buttittaauthor=M.+Incarboneauthor=L.+Toschiauthor=G.+Finocchiaroauthor=A.+Destroauthor=L.+Terraccianoauthor=M.+Roncalliauthor=M.+Alloisioauthor=A.+Santoroauthor=M.+Varella-Garcia&title=Increased+MET+gene+copy+number+negatively+affects+survival+of+surgically+resected+non-small+cell+lung+cancer+patients&doi=10.1200%2FJCO.2008.19.1635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients</span></div><div class="casAuthors">Cappuzzo Federico; Marchetti Antonio; Skokan Margaret; Rossi Elisa; Gajapathy Sujatha; Felicioni Lara; Del Grammastro Maela; Sciarrotta Maria Grazia; Buttitta Fiamma; Incarbone Matteo; Toschi Luca; Finocchiaro Giovanna; Destro Annarita; Terracciano Luigi; Roncalli Massimo; Alloisio Marco; Santoro Armando; Varella-Garcia Marileila</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1667-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To investigate the prognostic role of genomic gain for MET and epidermal growth factor receptor (EGFR) genes in surgically resected non-small-cell lung cancer (NSCLC).  PATIENTS AND METHODS:  This retrospective study included 447 NSCLC patients with available tumor tissue from primary lung tumor and survival data.  EGFR and MET status was evaluated by fluorescent in situ hybridization (FISH) in tissue microarray sections.  RESULTS:  EGFR FISH results were obtained in 376 cases.  EGFR gene amplification and high polysomy (EGFR FISH+) were observed in 10.4% and 32.4% of cases, respectively.  EGFR FISH-positive patients had a nonsignificant shorter survival than EGFR FISH-negative patients (P = .4).  Activating EGFR mutations were detected in 9.7% of 144 stage I-II disease with no impact on survival.  MET FISH analysis was performed in 435 cases.  High MET gene copy number (mean > or = 5 copies/cell) was observed in 48 cases (MET+, 11.1%), including 18 cases with true gene amplification (4.1%).  MET+ status was associated with advanced stage (P = .01), with grade 3 (P = .016) and with EGFR FISH+ result (P < .0001).  No patient with activating EGFR mutation resulted MET+.  In the whole population, MET-positive patients had shorter survival than MET-negative patients (P = .005).  Multivariable model confirmed that MET-negative patients had a significant reduction in the risk of death than MET-positive patients (hazard ratio, 0.66; P = .04).  CONCLUSION:  MET increased gene copy number is an independent negative prognostic factor in surgically resected NSCLC.  EGFR gene gain does not impact survival after resection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnc5G-Os6-WzdblLE_E9PWfW6udTcc2ea8c1Bp2FpNv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ktlKruw%253D%253D&md5=41bfbb70eb8a9e4ffd2964caf68e2511</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.19.1635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.19.1635%26sid%3Dliteratum%253Aachs%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DSkokan%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DE.%26aulast%3DGajapathy%26aufirst%3DS.%26aulast%3DFelicioni%26aufirst%3DL.%26aulast%3DDel%2BGrammastro%26aufirst%3DM.%26aulast%3DSciarrotta%26aufirst%3DM.%2BG.%26aulast%3DButtitta%26aufirst%3DF.%26aulast%3DIncarbone%26aufirst%3DM.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DDestro%26aufirst%3DA.%26aulast%3DTerracciano%26aufirst%3DL.%26aulast%3DRoncalli%26aufirst%3DM.%26aulast%3DAlloisio%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26atitle%3DIncreased%2520MET%2520gene%2520copy%2520number%2520negatively%2520affects%2520survival%2520of%2520surgically%2520resected%2520non-small%2520cell%2520lung%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26issue%3D10%26spage%3D1667%26epage%3D1674%26doi%3D10.1200%2FJCO.2008.19.1635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsudomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span> </span><span class="NLM_article-title">MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1043</span><span class="refDoi"> DOI: 10.1126/science.1141478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1126%2Fscience.1141478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=17463250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1039-1043&author=J.+A.+Engelmanauthor=K.+Zejnullahuauthor=T.+Mitsudomiauthor=Y.+Songauthor=C.+Hylandauthor=J.+O.+Parkauthor=N.+Lindemanauthor=C.+M.+Galeauthor=X.+Zhaoauthor=J.+Christensenauthor=T.+Kosakaauthor=A.+J.+Holmesauthor=A.+M.+Rogersauthor=F.+Cappuzzoauthor=T.+Mokauthor=C.+Leeauthor=B.+E.+Johnsonauthor=L.+C.+Cantleyauthor=P.+A.+J%C3%A4nne&title=MET+amplification+leads+to+gefitinib+resistance+in+lung+cancer+by+activating+ERBB3+signaling&doi=10.1126%2Fscience.1141478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling</span></div><div class="casAuthors">Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Song, Youngchul; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Zhao, Xiaojun; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; Rogers, Andrew M.; Cappuzzo, Federico; Mok, Tony; Lee, Charles; Johnson, Bruce E.; Cantley, Lewis C.; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5827</span>),
    <span class="NLM_cas:pages">1039-1043</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance.  Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib.  MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib.  We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors.  Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr430gbvBeIoLVg90H21EOLACvtfcHk0lg9Ntz4b5MV5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOjt7g%253D&md5=3da9383b4acb965f57529b095f8f4686</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1141478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1141478%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMitsudomi%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DJ.%2BO.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DGale%26aufirst%3DC.%2BM.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DRogers%26aufirst%3DA.%2BM.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DMok%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DMET%2520amplification%2520leads%2520to%2520gefitinib%2520resistance%2520in%2520lung%2520cancer%2520by%2520activating%2520ERBB3%2520signaling%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1039%26epage%3D1043%26doi%3D10.1126%2Fscience.1141478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bean, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riely, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szoke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladanyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">20932</span><span class="NLM_x">–</span> <span class="NLM_lpage">20937</span><span class="refDoi"> DOI: 10.1073/pnas.0710370104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0710370104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=18093943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=20932-20937&author=J.+Beanauthor=C.+Brennanauthor=J.+Y.+Shihauthor=G.+Rielyauthor=A.+Vialeauthor=L.+Wangauthor=D.+Chitaleauthor=N.+Motoiauthor=J.+Szokeauthor=S.+Broderickauthor=M.+Balakauthor=W.+C.+Changauthor=C.+J.+Yuauthor=A.+Gazdarauthor=H.+Passauthor=V.+Ruschauthor=W.+Geraldauthor=S.+F.+Huangauthor=P.+C.+Yangauthor=V.+Millerauthor=M.+Ladanyiauthor=C.+H.+Yangauthor=W.+Pao&title=MET+amplification+occurs+with+or+without+T790M+mutations+in+EGFR+mutant+lung+tumors+with+acquired+resistance+to+gefitinib+or+erlotinib&doi=10.1073%2Fpnas.0710370104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Met amplification occurs with or without T790m mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib</span></div><div class="casAuthors">Bean, James; Brennan, Cameron; Shih, Jin-Yuan; Riely, Gregory; Viale, Agnes; Wang, Lu; Chitale, Dhananjay; Motoi, Noriko; Szoke, Janos; Broderick, Stephen; Balak, Marissa; Chang, Wen-Cheng; Yu, Chong-Jen; Gazdar, Adi; Pass, Harvey; Rusch, Valerie; Gerald, William; Huang, Shiu-Feng; Yang, Pan-Chyr; Miller, Vincent; Ladanyi, Marc; Yang, Chih-Hsin; Pao, William</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">20932-20937</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In human lung adenocarcinomas harboring EGFR mutations, a second-site point mutation that substitutes methionine for threonine at position 790 (T790M) is assocd. with approx. half of cases of acquired resistance to the EGFR kinase inhibitors, gefitinib and erlotinib.  To identify other potential mechanisms that contribute to disease progression, we used array-based comparative genomic hybridization (aCGH) to compare genomic profiles of EGFR mutant tumors from untreated patients with those from patients with acquired resistance.  Among three loci demonstrating recurrent copy no. alterations (CNAs) specific to the acquired resistance set, one contained the MET proto-oncogene.  Collectively, anal. of tumor samples from multiple independent patient cohorts revealed that MET was amplified in tumors from 9 of 43 (21%) patients with acquired resistance but in only two tumors from 62 untreated patients (3%) (P = 0.007, Fisher's Exact test).  Among 10 resistant tumors from the nine patients with MET amplification, 4 also harbored the EGFRT790M mutation.  We also found that an existing EGFR mutant lung adenocarcinoma cell line, NCI-H820, harbors MET amplification in addn. to a drug-sensitive EGFR mutation and the T790M change.  Growth inhibition studies demonstrate that these cells are resistant to both erlotinib and an irreversible EGFR inhibitor (CL-387,785) but sensitive to a multikinase inhibitor (XL880) with potent activity against MET.  Taken together, these data suggest that MET amplification occurs independently of EGFRT790M mutations and that MET may be a clin. relevant therapeutic target for some patients with acquired resistance to gefitinib or erlotinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVkBqKpZ-f97Vg90H21EOLACvtfcHk0lg9Ntz4b5MV5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlyhsg%253D%253D&md5=3c80cf95fd68733e20b469e79035e721</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710370104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710370104%26sid%3Dliteratum%253Aachs%26aulast%3DBean%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DShih%26aufirst%3DJ.%2BY.%26aulast%3DRiely%26aufirst%3DG.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChitale%26aufirst%3DD.%26aulast%3DMotoi%26aufirst%3DN.%26aulast%3DSzoke%26aufirst%3DJ.%26aulast%3DBroderick%26aufirst%3DS.%26aulast%3DBalak%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DW.%2BC.%26aulast%3DYu%26aufirst%3DC.%2BJ.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPass%26aufirst%3DH.%26aulast%3DRusch%26aufirst%3DV.%26aulast%3DGerald%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DS.%2BF.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DMiller%26aufirst%3DV.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DMET%2520amplification%2520occurs%2520with%2520or%2520without%2520T790M%2520mutations%2520in%2520EGFR%2520mutant%2520lung%2520tumors%2520with%2520acquired%2520resistance%2520to%2520gefitinib%2520or%2520erlotinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D20932%26epage%3D20937%26doi%3D10.1073%2Fpnas.0710370104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias-Santagata, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digumarthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turke, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergethon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosper, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhavanfard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heist, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernovsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanuti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">75ra26</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3002003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1126%2Fscitranslmed.3002003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21430269" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=75ra26&author=L.+V.+Sequistauthor=B.+A.+Waltmanauthor=D.+Dias-Santagataauthor=S.+Digumarthyauthor=A.+B.+Turkeauthor=P.+Fidiasauthor=K.+Bergethonauthor=A.+T.+Shawauthor=S.+Gettingerauthor=A.+K.+Cosperauthor=S.+Akhavanfardauthor=R.+S.+Heistauthor=J.+Temelauthor=J.+G.+Christensenauthor=J.+C.+Wainauthor=T.+J.+Lynchauthor=K.+Vernovskyauthor=E.+J.+Markauthor=M.+Lanutiauthor=A.+J.+Iafrateauthor=M.+Mino-Kenudsonauthor=J.+A.+Engelman&title=Genotypic+and+histological+evolution+of+lung+cancers+acquiring+resistance+to+EGFR+inhibitors&doi=10.1126%2Fscitranslmed.3002003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002003%26sid%3Dliteratum%253Aachs%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DWaltman%26aufirst%3DB.%2BA.%26aulast%3DDias-Santagata%26aufirst%3DD.%26aulast%3DDigumarthy%26aufirst%3DS.%26aulast%3DTurke%26aufirst%3DA.%2BB.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DBergethon%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DGettinger%26aufirst%3DS.%26aulast%3DCosper%26aufirst%3DA.%2BK.%26aulast%3DAkhavanfard%26aufirst%3DS.%26aulast%3DHeist%26aufirst%3DR.%2BS.%26aulast%3DTemel%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DWain%26aufirst%3DJ.%2BC.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DVernovsky%26aufirst%3DK.%26aulast%3DMark%26aufirst%3DE.%2BJ.%26aulast%3DLanuti%26aufirst%3DM.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DGenotypic%2520and%2520histological%2520evolution%2520of%2520lung%2520cancers%2520acquiring%2520resistance%2520to%2520EGFR%2520inhibitors%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D75ra26%26doi%3D10.1126%2Fscitranslmed.3002003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtorta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siravegna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartore-Bianchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassingena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zecchin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apicella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galimi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauricella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronese, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amatu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nicolantonio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siena, S.</span><span> </span><span class="NLM_article-title">Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F2159-8290.CD-12-0558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=23729478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=658-673&author=A.+Bardelliauthor=S.+Corsoauthor=A.+Bertottiauthor=S.+Hoborauthor=E.+Valtortaauthor=G.+Siravegnaauthor=A.+Sartore-Bianchiauthor=E.+Scalaauthor=A.+Cassingenaauthor=D.+Zecchinauthor=M.+Apicellaauthor=G.+Migliardiauthor=F.+Galimiauthor=C.+Lauricellaauthor=C.+Zanonauthor=T.+Pereraauthor=S.+Veroneseauthor=G.+Cortiauthor=A.+Amatuauthor=M.+Gambacortaauthor=L.+A.+Diazauthor=M.+Sausenauthor=V.+E.+Velculescuauthor=P.+Comoglioauthor=L.+Trusolinoauthor=F.+Di+Nicolantonioauthor=S.+Giordanoauthor=S.+Siena&title=Amplification+of+the+MET+receptor+drives+resistance+to+anti-EGFR+therapies+in+colorectal+cancer&doi=10.1158%2F2159-8290.CD-12-0558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer</span></div><div class="casAuthors">Bardelli, Alberto; Corso, Simona; Bertotti, Andrea; Hobor, Sebastijan; Valtorta, Emanuele; Siravegna, Giulia; Sartore-Bianchi, Andrea; Scala, Elisa; Cassingena, Andrea; Zecchin, Davide; Apicella, Maria; Migliardi, Giorgia; Galimi, Francesco; Lauricella, Calogero; Zanon, Carlo; Perera, Timothy; Veronese, Silvio; Corti, Giorgio; Amatu, Alessio; Gambacorta, Marcello; Diaz, Luis A., Jr; Sausen, Mark; Velculescu, Victor E.; Comoglio, Paolo; Trusolino, Livio; Di Nicolantonio, Federica; Giordano, Silvia; Siena, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">658-673</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">EGF receptor (EGFR)-targeted monoclonal antibodies are effective in a subset of metastatic colorectal cancers.  Inevitably, all patients develop resistance, which occurs through emergence of KRAS mutations in approx. 50% of the cases.  We show that amplification of the MET proto-oncogene is assocd. with acquired resistance in tumors that do not develop KRAS mutations during anti-EGFR therapy.  Amplification of the MET locus was present in circulating tumor DNA before relapse was clin. evident.  Functional studies show that MET activation confers resistance to anti-EGFR therapy both in vitro and in vivo.  Notably, in patient-derived colorectal cancer xenografts, MET amplification correlated with resistance to EGFR blockade, which could be overcome by MET kinase inhibitors.  These results highlight the role of MET in mediating primary and secondary resistance to anti-EGFR therapies in colorectal cancer and encourage the use of MET inhibitors in patients displaying resistance as a result of MET amplification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhBSlKSNbwu7Vg90H21EOLACvtfcHk0li2pPc565udCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOrt7Y%253D&md5=68e7b07e9b39644949db4e0d6fe63af9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0558%26sid%3Dliteratum%253Aachs%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCorso%26aufirst%3DS.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DHobor%26aufirst%3DS.%26aulast%3DValtorta%26aufirst%3DE.%26aulast%3DSiravegna%26aufirst%3DG.%26aulast%3DSartore-Bianchi%26aufirst%3DA.%26aulast%3DScala%26aufirst%3DE.%26aulast%3DCassingena%26aufirst%3DA.%26aulast%3DZecchin%26aufirst%3DD.%26aulast%3DApicella%26aufirst%3DM.%26aulast%3DMigliardi%26aufirst%3DG.%26aulast%3DGalimi%26aufirst%3DF.%26aulast%3DLauricella%26aufirst%3DC.%26aulast%3DZanon%26aufirst%3DC.%26aulast%3DPerera%26aufirst%3DT.%26aulast%3DVeronese%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DG.%26aulast%3DAmatu%26aufirst%3DA.%26aulast%3DGambacorta%26aufirst%3DM.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DSausen%26aufirst%3DM.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DComoglio%26aufirst%3DP.%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DSiena%26aufirst%3DS.%26atitle%3DAmplification%2520of%2520the%2520MET%2520receptor%2520drives%2520resistance%2520to%2520anti-EGFR%2520therapies%2520in%2520colorectal%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D658%26epage%3D673%26doi%3D10.1158%2F2159-8290.CD-12-0558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Straussman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barzily-Rokni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mongare, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wargo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span> </span><span class="NLM_article-title">Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1038/nature11183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1038%2Fnature11183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=22763439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=500-504&author=R.+Straussmanauthor=T.+Morikawaauthor=K.+Sheeauthor=M.+Barzily-Rokniauthor=Z.+R.+Qianauthor=J.+Duauthor=A.+Davisauthor=M.+M.+Mongareauthor=J.+Gouldauthor=D.+T.+Frederickauthor=Z.+A.+Cooperauthor=P.+B.+Chapmanauthor=D.+B.+Solitauthor=A.+Ribasauthor=R.+S.+Loauthor=K.+T.+Flahertyauthor=S.+Oginoauthor=J.+A.+Wargoauthor=T.+R.+Golub&title=Tumour+micro-environment+elicits+innate+resistance+to+RAF+inhibitors+through+HGF+secretion&doi=10.1038%2Fnature11183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion</span></div><div class="casAuthors">Straussman, Ravid; Morikawa, Teppei; Shee, Kevin; Barzily-Rokni, Michal; Qian, Zhi Rong; Du, Jinyan; Davis, Ashli; Mongare, Margaret M.; Gould, Joshua; Frederick, Dennie T.; Cooper, Zachary A.; Chapman, Paul B.; Solit, David B.; Ribas, Antoni; Lo, Roger S.; Flaherty, Keith T.; Ogino, Shuji; Wargo, Jennifer A.; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7408</span>),
    <span class="NLM_cas:pages">500-504</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug resistance presents a challenge to the treatment of cancer patients.  Many studies have focused on cell-autonomous mechanisms of drug resistance.  By contrast, the authors proposed that the tumor micro-environment confers innate resistance to therapy.  Here the authors developed a co-culture system to systematically assay the ability of 23 stromal cell types to influence the innate resistance of 45 cancer cell lines to 35 anticancer drugs.  The authors found that stroma-mediated resistance is common, particularly to targeted agents.  The authors characterized further the stroma-mediated resistance of BRAF-mutant melanoma to RAF inhibitors because most patients with this type of cancer show some degree of innate resistance.  Proteomic anal. showed that stromal cell secretion of hepatocyte growth factor (HGF) resulted in activation of the HGF receptor MET, reactivation of the mitogen-activated protein kinase (MAPK), and phosphatidylinositol-3-OH kinase (PI(3)K)-AKT signaling pathways, and immediate resistance to RAF inhibition.  Immunohistochem. expts. confirmed stromal cell expression of HGF in patients with BRAF-mutant melanoma and showed a significant correlation between HGF expression by stromal cells and innate resistance to RAF inhibitor treatment.  Dual inhibition of RAF and either HGF or MET resulted in reversal of drug resistance, suggesting RAF plus HGF or MET inhibitory combination therapy as a potential therapeutic strategy for BRAF-mutant melanoma.  A similar resistance mechanism was uncovered in a subset of BRAF-mutant colorectal and glioblastoma cell lines.  More generally, this study indicates that the systematic dissection of interactions between tumors and their micro-environment can uncover important mechanisms underlying drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwanlhJUTP4LVg90H21EOLACvtfcHk0li2pPc565udCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjtL3J&md5=0616b5feed3c5dc2a53ee2ee382a6c33</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature11183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11183%26sid%3Dliteratum%253Aachs%26aulast%3DStraussman%26aufirst%3DR.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DBarzily-Rokni%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DZ.%2BR.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DMongare%26aufirst%3DM.%2BM.%26aulast%3DGould%26aufirst%3DJ.%26aulast%3DFrederick%26aufirst%3DD.%2BT.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DLo%26aufirst%3DR.%2BS.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DOgino%26aufirst%3DS.%26aulast%3DWargo%26aufirst%3DJ.%2BA.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DTumour%2520micro-environment%2520elicits%2520innate%2520resistance%2520to%2520RAF%2520inhibitors%2520through%2520HGF%2520secretion%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D500%26epage%3D504%26doi%3D10.1038%2Fnature11183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marando, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behshad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span> </span><span class="NLM_article-title">A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7127</span><span class="NLM_x">–</span> <span class="NLM_lpage">7138</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1078-0432.CCR-11-1157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21918175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7127-7138&author=X.+Liuauthor=Q.+Wangauthor=G.+Yangauthor=C.+Marandoauthor=H.+K.+Koblishauthor=L.+M.+Hallauthor=J.+S.+Fridmanauthor=E.+Behshadauthor=R.+Wynnauthor=Y.+Liauthor=J.+Boerauthor=S.+Diamondauthor=C.+Heauthor=M.+Xuauthor=J.+Zhuoauthor=W.+Yaoauthor=R.+C.+Newtonauthor=P.+A.+Scherle&title=A+novel+kinase+inhibitor%2C+INCB28060%2C+blocks+c-MET-dependent+signaling%2C+neoplastic+activities%2C+and+cross-talk+with+EGFR+and+HER-3&doi=10.1158%2F1078-0432.CCR-11-1157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3</span></div><div class="casAuthors">Liu, Xiangdong; Wang, Qian; Yang, Gengjie; Marando, Cindy; Koblish, Holly K.; Hall, Leslie M.; Fridman, Jordan S.; Behshad, Elham; Wynn, Richard; Li, Yu; Boer, Jason; Diamond, Sharon; He, Chunhong; Xu, Meizhong; Zhuo, Jincong; Yao, Wenqing; Newton, Robert C.; Scherle, Peggy A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7127-7138</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The c-MET receptor tyrosine kinase plays important roles in the formation, progression, and dissemination of human cancer and presents an attractive therapeutic target.  This study describes the preclin. characterization of INCB28060, a novel inhibitor of c-MET kinase.  Exptl. Design: Studies were conducted using a series of in vitro and in vivo biochem. and biol. expts.  RESULTS: INCB28060 exhibits picomolar enzymic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases.  This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.  As a result, INCB28060 potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis in vitro.  Oral dosing of INCB28060 results in time- and dose-dependent inhibition of c-MET phosphorylation and tumor growth in c-MET-driven mouse tumor models, and the inhibitor is well tolerated at doses that achieve complete tumor inhibition.  In a further exploration of potential interactions between c-MET and other signaling pathways, we found that activated c-MET pos. regulates the activity of epidermal growth factor receptors (EGFR) and HER-3, as well as expression of their ligands.  These effects are reversed with INCB28060 treatment.  Finally, we confirmed that circulating hepatocyte growth factor levels are significantly elevated in patients with various cancers.  CONCLUSIONS: Activated c-MET has pleiotropic effects on multiple cancer-promoting signaling pathways and may play a crit. role in driving tumor cell growth and survival.  INCB28060 is a potent and selective c-MET kinase inhibitor that may have therapeutic potential in cancer treatment.  Clin Cancer Res; 17(22); 7127-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqT6dM1mGprVg90H21EOLACvtfcHk0li2pPc565udCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nK&md5=c272514704702cb5cbcc9e405bea3c53</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1157%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DMarando%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DHall%26aufirst%3DL.%2BM.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBehshad%26aufirst%3DE.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520kinase%2520inhibitor%252C%2520INCB28060%252C%2520blocks%2520c-MET-dependent%2520signaling%252C%2520neoplastic%2520activities%252C%2520and%2520cross-talk%2520with%2520EGFR%2520and%2520HER-3%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D7127%26epage%3D7138%26doi%3D10.1158%2F1078-0432.CCR-11-1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bladt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friese-Hamim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuehl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fittschen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyring, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaehrling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehl, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaukat, A.</span><span> </span><span class="NLM_article-title">EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2941</span><span class="NLM_x">–</span> <span class="NLM_lpage">2951</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1078-0432.CCR-12-3247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=23553846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos12ju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2941-2951&author=F.+Bladtauthor=B.+Fadenauthor=M.+Friese-Hamimauthor=C.+Knuehlauthor=C.+Wilmauthor=C.+Fittschenauthor=U.+Gradlerauthor=M.+Meyringauthor=D.+Dorschauthor=F.+Jaehrlingauthor=U.+Pehlauthor=F.+Stieberauthor=O.+Schadtauthor=A.+Blaukat&title=EMD+1214063+and+EMD+1204831+constitute+a+new+class+of+potent+and+highly+selective+c-Met+inhibitors&doi=10.1158%2F1078-0432.CCR-12-3247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors</span></div><div class="casAuthors">Bladt, Friedhelm; Faden, Bettina; Friese-Hamim, Manja; Knuehl, Christine; Wilm, Claudia; Fittschen, Claus; Graedler, Ulrich; Meyring, Michael; Dorsch, Dieter; Jaehrling, Frank; Pehl, Ulrich; Stieber, Frank; Schadt, Oliver; Blaukat, Andree</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2941-2951</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The mesenchymal-epithelial transition factor (c-Met) receptor, also known as hepatocyte growth factor receptor (HGFR), controls morphogenesis, a process that is physiol. required for embryonic development and tissue repair.  Aberrant c-Met activation is assocd. with a variety of human malignancies including cancers of the lung, kidney, stomach, liver, and brain.  In this study, we investigated the properties of two novel compds. developed to selectively inhibit the c-Met receptor in antitumor therapeutic interventions.  Exptl. Design: The pharmacol. properties, c-Met inhibitory activity, and antitumor effects of EMD 1214063 and EMD 1204831 were investigated in vitro and in vivo, using human cancer cell lines and mouse xenograft models.  Results: EMD 1214063 and EMD 1204831 selectively suppressed the c-Met receptor tyrosine kinase activity.  Their inhibitory activity was potent [inhibitory 50% concn. (IC50), 3 nmol/L and 9 nmol/L, resp.] and highly selective, when compared with their effect on a panel of 242 human kinases.  Both EMD 1214063 and EMD 1204831 inhibited c-Met phosphorylation and downstream signaling in a dose-dependent fashion, but differed in the duration of their inhibitory activity.  In murine xenograft models, both compds. induced regression of human tumors, regardless of whether c-Met activation was HGF dependent or independent.  Both drugs were well tolerated and induced no substantial wt. loss after more than 3 wk of treatment.  Conclusions: Our results indicate selective c-Met inhibition by EMD 1214063 and EMD 1204831 and strongly support clin. testing of these compds. in the context of molecularly targeted anticancer strategies.  Clin Cancer Res; 19(11); 2941-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2ZWzE5rC6LVg90H21EOLACvtfcHk0lhLucuL8_m28g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos12ju78%253D&md5=a1d24bf9fdaea35808c7468a6e7d197f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3247%26sid%3Dliteratum%253Aachs%26aulast%3DBladt%26aufirst%3DF.%26aulast%3DFaden%26aufirst%3DB.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DKnuehl%26aufirst%3DC.%26aulast%3DWilm%26aufirst%3DC.%26aulast%3DFittschen%26aufirst%3DC.%26aulast%3DGradler%26aufirst%3DU.%26aulast%3DMeyring%26aufirst%3DM.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DJaehrling%26aufirst%3DF.%26aulast%3DPehl%26aufirst%3DU.%26aulast%3DStieber%26aufirst%3DF.%26aulast%3DSchadt%26aufirst%3DO.%26aulast%3DBlaukat%26aufirst%3DA.%26atitle%3DEMD%25201214063%2520and%2520EMD%25201204831%2520constitute%2520a%2520new%2520class%2520of%2520potent%2520and%2520highly%2520selective%2520c-Met%2520inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D2941%26epage%3D2951%26doi%3D10.1158%2F1078-0432.CCR-12-3247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, W.</span><span> </span><span class="NLM_article-title">Discovery of (S)-1-(1-(imidazo[1,2- a ]pyridin-6-yl)ethyl)-6-(1-methyl-1 H -pyrazol-4-yl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7577</span><span class="NLM_x">–</span> <span class="NLM_lpage">7589</span><span class="refDoi"> DOI: 10.1021/jm500510f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500510f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7577-7589&author=H.+Jiaauthor=G.+Daiauthor=J.+Wengauthor=Z.+Zhangauthor=Q.+Wangauthor=F.+Zhouauthor=L.+Jiaoauthor=Y.+Cuiauthor=Y.+Renauthor=S.+Fanauthor=J.+Zhouauthor=W.+Qingauthor=Y.+Guauthor=J.+Wangauthor=Y.+Saiauthor=W.+Su&title=Discovery+of+%28S%29-1-%281-%28imidazo%5B1%2C2-+a+%5Dpyridin-6-yl%29ethyl%29-6-%281-methyl-1+H+-pyrazol-4-yl%29-1+H+-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-+b+%5Dpyrazine+%28volitinib%29+as+a+highly+potent+and+selective+mesenchymal-epithelial+transition+factor+%28c-Met%29+inhibitor+in+clinical+development+for+treatment+of+cancer&doi=10.1021%2Fjm500510f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm500510f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500510f%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%2528imidazo%255B1%252C2-%2520a%2520%255Dpyridin-6-yl%2529ethyl%2529-6-%25281-methyl-1%2520H%2520-pyrazol-4-yl%2529-1%2520H%2520-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-%2520b%2520%255Dpyrazine%2520%2528volitinib%2529%2520as%2520a%2520highly%2520potent%2520and%2520selective%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-Met%2529%2520inhibitor%2520in%2520clinical%2520development%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7577%26epage%3D7589%26doi%3D10.1021%2Fjm500510f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hughes, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caenepeel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">19 Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">728</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1538-7445.AM2014-728" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=728&issue=19+Suppl.&author=P.+E.+Hughesauthor=Y.+Yangauthor=K.+Rexauthor=Y.+Zhangauthor=P.+J.+Kaplan-Lefkoauthor=S.+Caenepeelauthor=J.+Moriguchiauthor=M.+Broomeauthor=D.+Choquetteauthor=R.+Radinskyauthor=R.+Kendallauthor=A.+Coxonauthor=I.+Dussault&title=AMG+337%2C+a+novel%2C+potent+and+selective+MET+kinase+inhibitor%2C+has+robust+growth+inhibitory+activity+in+MET-dependent+cancer+models&doi=10.1158%2F1538-7445.AM2014-728"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-728%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DP.%2BE.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DCaenepeel%26aufirst%3DS.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DBroome%26aufirst%3DM.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DRadinsky%26aufirst%3DR.%26aulast%3DKendall%26aufirst%3DR.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DAMG%2520337%252C%2520a%2520novel%252C%2520potent%2520and%2520selective%2520MET%2520kinase%2520inhibitor%252C%2520has%2520robust%2520growth%2520inhibitory%2520activity%2520in%2520MET-dependent%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D19%2520Suppl%26spage%3D728%26doi%3D10.1158%2F1538-7445.AM2014-728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Okamoto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span> </span><span class="NLM_article-title">Antitumor action of the MET tyrosine kinase inhibitor Crizotinib (PF-02341066) in gastric cancer positive for MET amplification</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1535-7163.MCT-11-0934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=22729845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1557-1564&author=W.+Okamotoauthor=I.+Okamotoauthor=T.+Araoauthor=K.+Kuwataauthor=H.+Yamaguchiauthor=K.+Sakaiauthor=K.+Yanagiharaauthor=K.+Nishioauthor=K.+Nakagawa&title=Antitumor+action+of+the+MET+tyrosine+kinase+inhibitor+Crizotinib+%28PF-02341066%29+in+gastric+cancer+positive+for+MET+amplification&doi=10.1158%2F1535-7163.MCT-11-0934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for MET Amplification</span></div><div class="casAuthors">Okamoto, Wataru; Okamoto, Isamu; Arao, Tokuzo; Kuwata, Kiyoko; Hatashita, Erina; Yamaguchi, Haruka; Sakai, Kazuko; Yanagihara, Kazuyoshi; Nishio, Kazuto; Nakagawa, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1557-1564</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Therapeutic strategies that target the tyrosine kinase MET hold promise for gastric cancer, but the mechanism underlying the antitumor activity of such strategies remains unclear.  We examd. the antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer cells pos. or neg. for MET amplification.  Inhibition of MET signaling by crizotinib or RNA interference-mediated MET depletion resulted in induction of apoptosis accompanied by inhibition of AKT and extracellular signal-regulated kinase phosphorylation in gastric cancer cells with MET amplification but not in those without it, suggesting that MET signaling is essential for the survival of MET amplification-pos. cells.  Crizotinib upregulated the expression of BIM, a proapoptotic member of the Bcl-2 family, as well as downregulated that of survivin, X-linked inhibitor of apoptosis protein (XIAP), and c-IAP1, members of the inhibitor of apoptosis protein family, in cells with MET amplification.  Forced depletion of BIM inhibited crizotinib-induced apoptosis, suggesting that upregulation of BIM contributes to the proapoptotic effect of crizotinib.  Crizotinib also exhibited a marked antitumor effect in gastric cancer xenografts pos. for MET amplification, whereas it had little effect on those neg. for this genetic change.  Crizotinib thus shows a marked antitumor action both in vitro and in vivo specifically in gastric cancer cells pos. for MET amplification.  Mol Cancer Ther; 11(7); 1557-64. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6365v7Z1HwbVg90H21EOLACvtfcHk0lgCamZ-xEYmdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKrtbc%253D&md5=fe2d495e894f32795eedcc8de80c7e14</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0934%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DW.%26aulast%3DOkamoto%26aufirst%3DI.%26aulast%3DArao%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DYanagihara%26aufirst%3DK.%26aulast%3DNishio%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DK.%26atitle%3DAntitumor%2520action%2520of%2520the%2520MET%2520tyrosine%2520kinase%2520inhibitor%2520Crizotinib%2520%2528PF-02341066%2529%2520in%2520gastric%2520cancer%2520positive%2520for%2520MET%2520amplification%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D1557%26epage%3D1564%26doi%3D10.1158%2F1535-7163.MCT-11-0934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemecek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wentzler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grapinet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khider, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dischamps, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnefraud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacqué, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenigsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span> </span><span class="NLM_article-title">SAR125844: a potent and selective ATP-competitive inhibitor of MET kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">8, Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">2911</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2012-2911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1538-7445.AM2012-2911" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2911&issue=8%2C+Suppl.+1&author=L.+Schioauthor=C.+Nemecekauthor=T.+Ugoliniauthor=S.+Wentzlerauthor=S.+Grapinetauthor=J.+Khiderauthor=E.+Albertauthor=N.+Dischampsauthor=F.+Gayauthor=V.+Sonnefraudauthor=E.+Bacqu%C3%A9author=M.+Kenigsbergauthor=H.+Goulaouicauthor=A.+Dagallierauthor=F.+Vall%C3%A9eauthor=F.+Boncheauthor=C.+Lengauer&title=SAR125844%3A+a+potent+and+selective+ATP-competitive+inhibitor+of+MET+kinase&doi=10.1158%2F1538-7445.AM2012-2911"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2012-2911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2012-2911%26sid%3Dliteratum%253Aachs%26aulast%3DSchio%26aufirst%3DL.%26aulast%3DNemecek%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DT.%26aulast%3DWentzler%26aufirst%3DS.%26aulast%3DGrapinet%26aufirst%3DS.%26aulast%3DKhider%26aufirst%3DJ.%26aulast%3DAlbert%26aufirst%3DE.%26aulast%3DDischamps%26aufirst%3DN.%26aulast%3DGay%26aufirst%3DF.%26aulast%3DSonnefraud%26aufirst%3DV.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26aulast%3DKenigsberg%26aufirst%3DM.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DDagallier%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DBonche%26aufirst%3DF.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DSAR125844%253A%2520a%2520potent%2520and%2520selective%2520ATP-competitive%2520inhibitor%2520of%2520MET%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D8%252C%2520Suppl.%25201%26spage%3D2911%26doi%3D10.1158%2F1538-7445.AM2012-2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Egile, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenigsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begassat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do-Vale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestadier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolas, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valence, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francesconi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemecek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span> </span><span class="NLM_article-title">The selective intravenous inhibitor of the MET tyrosine kinase SAR125844 inhibits tumor growth in MET-amplified cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1535-7163.MCT-14-0428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=25504634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlOjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=384-394&author=C.+Egileauthor=M.+Kenigsbergauthor=C.+Delaisiauthor=F.+Begassatauthor=V.+Do-Valeauthor=J.+Mestadierauthor=F.+Boncheauthor=T.+Benardauthor=J.+P.+Nicolasauthor=S.+Valenceauthor=C.+Lefrancauthor=E.+Francesconiauthor=C.+Castellauthor=A.+M.+Lefebvreauthor=C.+Nemecekauthor=L.+Calvetauthor=H.+Goulaouic&title=The+selective+intravenous+inhibitor+of+the+MET+tyrosine+kinase+SAR125844+inhibits+tumor+growth+in+MET-amplified+cancer&doi=10.1158%2F1535-7163.MCT-14-0428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in MET-Amplified Cancer</span></div><div class="casAuthors">Egile, Coumaran; Kenigsberg, Mireille; Delaisi, Christine; Begassat, Francoise; Do-Vale, Veronique; Mestadier, Jessica; Bonche, Fabrice; Benard, Tsiala; Nicolas, Jean-Paul; Valence, Sandrine; Lefranc, Celine; Francesconi, Elisa; Castell, Christelle; Lefebvre, Anne-Marie; Nemecek, Conception; Calvet, Loreley; Goulaouic, Helene</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-394</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of the MET/HGF pathway is common in human cancer and is thought to promote tumor initiation, metastasis, angiogenesis, and resistance to diverse therapies.  We report here the pharmacol. characterization of the triazolopyridazine deriv. SAR125844, a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK), for i.v. administration.  SAR125844 displayed nanomolar activity against the wild-type kinase (IC50 value of 4.2 nmol/L) and the M1250T and Y1235D mutants.  Broad biochem. profiling revealed that SAR125844 was highly selective for MET kinase.  SAR125844 inhibits MET autophosphorylation in cell-based assays in the nanomolar range, and promotes low nanomolar proapoptotic and antiproliferative activities selectively in cell lines with MET gene amplification or pathway addiction.  In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, i.v. treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.  Long duration of MET kinase inhibition up to 7 days was achieved with a nanosuspension formulation of SAR125844.  Daily or every-2-days i.v. treatment of SAR125844 promoted a dose-dependent tumor regression in MET-amplified human gastric cancer models at tolerated doses without treatment-related body wt. loss.  Our data demonstrated that SAR125844 is a potent and selective MET kinase inhibitor with a favorable preclin. toxicity profile, supporting its clin. development in patients with MET-amplified and MET pathway-addicted tumors.  Mol Cancer Ther; 14(2); 384-94. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphB-Rou5kYcLVg90H21EOLACvtfcHk0lgCamZ-xEYmdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlOjsb0%253D&md5=12a76fc417063f4b5d7cdc970f2ec605</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0428%26sid%3Dliteratum%253Aachs%26aulast%3DEgile%26aufirst%3DC.%26aulast%3DKenigsberg%26aufirst%3DM.%26aulast%3DDelaisi%26aufirst%3DC.%26aulast%3DBegassat%26aufirst%3DF.%26aulast%3DDo-Vale%26aufirst%3DV.%26aulast%3DMestadier%26aufirst%3DJ.%26aulast%3DBonche%26aufirst%3DF.%26aulast%3DBenard%26aufirst%3DT.%26aulast%3DNicolas%26aufirst%3DJ.%2BP.%26aulast%3DValence%26aufirst%3DS.%26aulast%3DLefranc%26aufirst%3DC.%26aulast%3DFrancesconi%26aufirst%3DE.%26aulast%3DCastell%26aufirst%3DC.%26aulast%3DLefebvre%26aufirst%3DA.%2BM.%26aulast%3DNemecek%26aufirst%3DC.%26aulast%3DCalvet%26aufirst%3DL.%26aulast%3DGoulaouic%26aufirst%3DH.%26atitle%3DThe%2520selective%2520intravenous%2520inhibitor%2520of%2520the%2520MET%2520tyrosine%2520kinase%2520SAR125844%2520inhibits%2520tumor%2520growth%2520in%2520MET-amplified%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D384%26epage%3D394%26doi%3D10.1158%2F1535-7163.MCT-14-0428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span><span class="refDoi"> DOI: 10.1021/cb500129t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500129t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1230-1241&author=Z.+Zhaoauthor=H.+Wuauthor=L.+Wangauthor=Y.+Liuauthor=S.+Knappauthor=Q.+Liuauthor=N.+S.+Gray&title=Exploration+of+type+II+binding+mode%3A+a+privileged+approach+for+kinase+inhibitor+focused+drug+discovery&doi=10.1021%2Fcb500129t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500129t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520of%2520type%2520II%2520binding%2520mode%253A%2520a%2520privileged%2520approach%2520for%2520kinase%2520inhibitor%2520focused%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1230%26epage%3D1241%26doi%3D10.1021%2Fcb500129t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M-H.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaida, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span> </span><span class="NLM_article-title">Discovery of (R)-6-(1-(8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-ethoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a potent and selective inhibitor of MET with high unbound target coverage and robust in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2328</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2328-2342&issue=6&author=A.+A.+Boezioauthor=K.+W.+Copelandauthor=K.+Rexauthor=B.+K.+Albrechtauthor=D.+Bauerauthor=S.+F.+Bellonauthor=C.+Boezioauthor=M.+A.+Broomeauthor=D.+Choquetteauthor=A.+Coxonauthor=I.+Dussaultauthor=S.+Hiraiauthor=R.+Lewisauthor=M-H.J.+Linauthor=J.+Lohmanauthor=J.+Liuauthor=E.+A.+Petersonauthor=M.+Potashmanauthor=R.+Shimanovichauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=K.+R.+Vaidaauthor=J.-C.+Harmange&title=Discovery+of+%28R%29-6-%281-%288-fluoro-6-%281-methyl-1H-pyrazol-4-yl%29-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridin-3-yl%29ethyl%29-3-%282-ethoxyethoxy%29-1%2C6-naphthyridin-5%286H%29-one+%28AMG+337%29%2C+a+potent+and+selective+inhibitor+of+MET+with+high+unbound+target+coverage+and+robust+in+vivo+antitumor+activity&doi=10.1021%2Facs.jmedchem.5b01716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01716%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DBroome%26aufirst%3DM.%2BA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DM-H.J.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-%25281-%25288-fluoro-6-%25281-methyl-1H-pyrazol-4-yl%2529-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529ethyl%2529-3-%25282-ethoxyethoxy%2529-1%252C6-naphthyridin-5%25286H%2529-one%2520%2528AMG%2520337%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520MET%2520with%2520high%2520unbound%2520target%2520coverage%2520and%2520robust%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2328%26epage%3D2342%26doi%3D10.1021%2Facs.jmedchem.5b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lolkema, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohets, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkenau, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Doorn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellemans, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskens, F. A.</span><span> </span><span class="NLM_article-title">The c-Met tyrosine kinase inhibitor JNJ-38877605 causes renal toxicity through species-specific insoluble metabolite formation</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1078-0432.CCR-14-3258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=25745036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2297-304&issue=10&author=M.+P.+Lolkemaauthor=H.+H.+Bohetsauthor=H.+T.+Arkenauauthor=A.+Lampoauthor=E.+Baraleauthor=M.+J.+de+Jongeauthor=L.+van+Doornauthor=P.+Hellemansauthor=J.+S.+de+Bonoauthor=F.+A.+Eskens&title=The+c-Met+tyrosine+kinase+inhibitor+JNJ-38877605+causes+renal+toxicity+through+species-specific+insoluble+metabolite+formation&doi=10.1158%2F1078-0432.CCR-14-3258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation</span></div><div class="casAuthors">Lolkema, Martijn P.; Bohets, Hilde H.; Arkenau, Hendrik-Tobias; Lampo, Ann; Barale, Erio; de Jonge, Maja J. A.; van Doorn, Leni; Hellemans, Peter; de Bono, Johann S.; Eskens, Ferry A. L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2297-2304</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The receptor tyrosine kinase c-Met plays an important role in tumorigenesis and is a novel target for anticancer treatment.  This phase I, first-in-human trial, explored safety, pharmacokinetics, pharmacodynamics, and initial antitumor activity of JNJ-38877605, a potent and selective c-Met inhibitor.  Exptl. Design: We performed a phase I dose-escalation study according to the std. 3+3 design.  Results: Even at subtherapeutic doses, mild though recurrent renal toxicity was obsd. in virtually all patients.  Renal toxicity had not been obsd. in preclin. studies in rats and dogs.  Addnl. preclin. studies pointed toward the rabbit as a suitable toxicol. model, as the formation of the M10 metabolite of JNJ-38877605 specifically occurred in rabbits and humans.  Addnl. toxicol. studies in rabbits clearly demonstrated that JNJ-38877605 induced species-specific renal toxicity.  Histopathol. evaluation in rabbits revealed renal crystal formation with degenerative and inflammatory changes.  Identification of the components of these renal crystals revealed M1/3 and M5/6 metabolites.  Accordingly, it was found that humans and rabbits showed significantly increased systemic exposure to these metabolites relative to other species.  These main culprit insol. metabolites were generated by aldehyde oxidase activity.  Alternative dosing schedules of JNJ-3877605 and concomitant probenecid administration in rabbits failed to prevent renal toxicity at dose levels that could be pharmacol. active.  Conclusions: Combined clin. and correlative preclin. studies suggest that renal toxicity of JNJ-38877605 is caused by the formation of species-specific insol. metabolites.  These observations preclude further clin. development of JNJ-38877605.  Clin Cancer Res; 21(10); 2297-304. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro1cpkCcM_IbVg90H21EOLACvtfcHk0lgCBKCcKrhefA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXoslOktbc%253D&md5=9900b077fbb0766d9c26b3908e7ee1c4</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3258%26sid%3Dliteratum%253Aachs%26aulast%3DLolkema%26aufirst%3DM.%2BP.%26aulast%3DBohets%26aufirst%3DH.%2BH.%26aulast%3DArkenau%26aufirst%3DH.%2BT.%26aulast%3DLampo%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DE.%26aulast%3Dde%2BJonge%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2BDoorn%26aufirst%3DL.%26aulast%3DHellemans%26aufirst%3DP.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DEskens%26aufirst%3DF.%2BA.%26atitle%3DThe%2520c-Met%2520tyrosine%2520kinase%2520inhibitor%2520JNJ-38877605%2520causes%2520renal%2520toxicity%2520through%2520species-specific%2520insoluble%2520metabolite%2520formation%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D10%26spage%3D2297%26epage%3D304%26doi%3D10.1158%2F1078-0432.CCR-14-3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounaud, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felce, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froning, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterman, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubol, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessert, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauder, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwinn, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emtage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burley, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, S. H.</span><span> </span><span class="NLM_article-title">SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3181</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1158%2F1535-7163.MCT-09-0477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=19934279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3181-90&issue=12&author=S.+G.+Buchananauthor=J.+Hendleauthor=P.+S.+Leeauthor=C.+R.+Smithauthor=P.+Y.+Bounaudauthor=K.+A.+Jessenauthor=C.+M.+Tangauthor=N.+H.+Huserauthor=J.+D.+Felceauthor=K.+J.+Froningauthor=M.+C.+Petermanauthor=B.+E.+Aubolauthor=S.+F.+Gessertauthor=J.+M.+Sauderauthor=K.+D.+Schwinnauthor=M.+Russellauthor=I.+A.+Rooneyauthor=J.+Adamsauthor=B.+C.+Leonauthor=T.+H.+Doauthor=J.+M.+Blaneyauthor=P.+A.+Sprengelerauthor=D.+A.+Thompsonauthor=L.+Smythauthor=L.+A.+Pelletierauthor=S.+Atwellauthor=K.+Holmeauthor=S.+R.+Wassermanauthor=S.+Emtageauthor=S.+K.+Burleyauthor=S.+H.+Reich&title=SGX523+is+an+exquisitely+selective%2C+ATP-competitive+inhibitor+of+the+MET+receptor+tyrosine+kinase+with+antitumor+activity+in+vivo&doi=10.1158%2F1535-7163.MCT-09-0477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo</span></div><div class="casAuthors">Buchanan, Sean G.; Hendle, Jorg; Lee, Patrick S.; Smith, Christopher R.; Bounaud, Pierre-Yves; Jessen, Katti A.; Tang, Crystal M.; Huser, Nanni H.; Felce, Jeremy D.; Froning, Karen J.; Peterman, Marshall C.; Aubol, Brandon E.; Gessert, Steve F.; Sauder, J. Michael; Schwinn, Kenneth D.; Russell, Marijane; Rooney, Isabelle A.; Adams, Jason; Leon, Barbara C.; Do, Tuan H.; Blaney, Jeff M.; Sprengeler, Paul A.; Thompson, Devon A.; Smyth, Lydia; Pelletier, Laura A.; Atwell, Shane; Holme, Kevin; Wasserman, Stephen R.; Emtage, Spencer; Burley, Stephen K.; Reich, Siegfried H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3181-3190</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The MET receptor tyrosine kinase has emerged as an important target for the development of novel cancer therapeutics.  Activation of MET by mutation or gene amplification has been linked to kidney, gastric, and lung cancers.  In other cancers, such as glioblastoma, autocrine activation of MET has been demonstrated.  Several classes of ATP-competitive inhibitor have been described, which inhibit MET but also other kinases.  Here, we describe SGX523, a novel, ATP-competitive kinase inhibitor remarkable for its exquisite selectivity for MET.  SGX523 potently inhibited MET with an IC50 of 4 nmol/L and is >1000-fold selective vs. the >200-fold selectivity of other protein kinases tested in biochem. assays.  Crystallog. study revealed that SGX523 stabilizes MET in a unique inactive conformation that is inaccessible to other protein kinases, suggesting an explanation for the selectivity.  SGX523 inhibited MET-mediated signaling, cell proliferation, and cell migration at nanomolar concns. but had no effect on signaling dependent on other protein kinases, including the closely related RON, even at micromolar concns.  SGX523 inhibition of MET in vivo was assocd. with the dose-dependent inhibition of growth of tumor xenografts derived from human glioblastoma and lung and gastric cancers, confirming the dependence of these tumors on MET catalytic activity.  Our results show that SGX523 is the most selective inhibitor of MET catalytic activity described to date and is thus a useful tool to investigate the role of MET kinase in cancer without the confounding effects of promiscuous protein kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplt9w6z--VQ7Vg90H21EOLACvtfcHk0lgCBKCcKrhefA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbzI&md5=7410ae811f0bf2d3298691ed34d35878</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0477%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DBounaud%26aufirst%3DP.%2BY.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DTang%26aufirst%3DC.%2BM.%26aulast%3DHuser%26aufirst%3DN.%2BH.%26aulast%3DFelce%26aufirst%3DJ.%2BD.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DPeterman%26aufirst%3DM.%2BC.%26aulast%3DAubol%26aufirst%3DB.%2BE.%26aulast%3DGessert%26aufirst%3DS.%2BF.%26aulast%3DSauder%26aufirst%3DJ.%2BM.%26aulast%3DSchwinn%26aufirst%3DK.%2BD.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DRooney%26aufirst%3DI.%2BA.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DDo%26aufirst%3DT.%2BH.%26aulast%3DBlaney%26aufirst%3DJ.%2BM.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DSmyth%26aufirst%3DL.%26aulast%3DPelletier%26aufirst%3DL.%2BA.%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DHolme%26aufirst%3DK.%26aulast%3DWasserman%26aufirst%3DS.%2BR.%26aulast%3DEmtage%26aufirst%3DS.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DSGX523%2520is%2520an%2520exquisitely%2520selective%252C%2520ATP-competitive%2520inhibitor%2520of%2520the%2520MET%2520receptor%2520tyrosine%2520kinase%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D12%26spage%3D3181%26epage%3D90%26doi%3D10.1158%2F1535-7163.MCT-09-0477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kawasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Finding a better path to drug selectivity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span><span class="refDoi"> DOI: 10.1016/j.drudis.2011.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1016%2Fj.drudis.2011.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=21839183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=985-990&author=Y.+Kawasakiauthor=E.+Freire&title=Finding+a+better+path+to+drug+selectivity&doi=10.1016%2Fj.drudis.2011.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a better path to drug selectivity</span></div><div class="casAuthors">Kawasaki, Yuko; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">985-990</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Extremely high affinity and selectivity are two of the most sought-after properties of drug mols.  Selectivity has been difficult to achieve, esp. for targets that belong to large families of structurally and functionally related proteins.  There are essentially two ways by which selectivity can be improved during lead optimization: a chem. modification of the lead compd. that improves the affinity towards the target to a higher extent than to off-target mols.; and a chem. modification that lowers the affinity of the lead compd. towards off-target mols.  Maximal selectivity is achieved when both mechanisms can be combined synergistically.  As we discuss here, anal. of several protease inhibitors that vary in a single functionality indicates that nonpolar functionalities preferentially follow the first mechanism, whereas polar functionalities follow the second, and that those features are imprinted in their thermodn. signatures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGj1IsjIk4bbVg90H21EOLACvtfcHk0libfMziz2LHHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWktbjF&md5=68ab56fd05adcdc61d12ee955b0fddc5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DFinding%2520a%2520better%2520path%2520to%2520drug%2520selectivity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D985%26epage%3D990%26doi%3D10.1016%2Fj.drudis.2011.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0libfMziz2LHHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F. T.</span><span> </span><span class="NLM_article-title">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17783</span><span class="NLM_x">–</span> <span class="NLM_lpage">17788</span><span class="refDoi"> DOI: 10.1073/pnas.0607656103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=10.1073%2Fpnas.0607656103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=17095602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17783-17788&author=A.+P.+Kornevauthor=N.+M.+Hasteauthor=S.+S.+Taylorauthor=L.+F.+T.+Ten+Eyck&title=Surface+comparison+of+active+and+inactive+protein+kinases+identifies+a+conserved+activation+mechanism&doi=10.1073%2Fpnas.0607656103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span></div><div class="casAuthors">Kornev, Alexandr P.; Haste, Nina M.; Taylor, Susan S.; Ten Eyck, Lynn F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17783-17788</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The surface comparison of different serine-threonine and tyrosine kinases reveals a set of 30 residues whose spatial positions are highly conserved.  The comparison between active and inactive conformations identified the residues whose positions are the most sensitive to activation.  Based on these results, we propose a model of protein kinase activation.  This model explains how the presence of a phosphate group in the activation loop dets. the position of the catalytically important aspartate in the Asp-Phe-Gly (DFG) motif.  According to the model, the most important feature of the activation is a "spine" formation that is dynamically assembled in all active kinases.  The spine is comprised of four hydrophobic residues that we detected in a set of 23 eukaryotic and prokaryotic kinases.  It spans the mol. and plays a coordinating role in activated kinases.  The spine is disordered in the inactive kinases and can explain how stabilization of the whole mol. is achieved upon phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwv4ByA5owH7Vg90H21EOLACvtfcHk0libfMziz2LHHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ&md5=f474acffd8b17d8352ac9f6fc9bbbf8f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0607656103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0607656103%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%2BT.%26atitle%3DSurface%2520comparison%2520of%2520active%2520and%2520inactive%2520protein%2520kinases%2520identifies%2520a%2520conserved%2520activation%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D17783%26epage%3D17788%26doi%3D10.1073%2Fpnas.0607656103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Albert, E.; Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S.</span><span> </span><span class="NLM_article-title">Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as MET inhibitors</span>. WO2009056692 A2; May 7,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Albert&author=E.+Bacque&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Novel+6-triazolopyridazinesulfanyl+benzothiazole+and+benzimidazole+derivatives%2C+method+for+production+thereof+and+application+as+medicaments+and+pharmaceutical+compositions+and+novel+use+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DE.%26atitle%3DNovel%25206-triazolopyridazinesulfanyl%2520benzothiazole%2520and%2520benzimidazole%2520derivatives%252C%2520method%2520for%2520production%2520thereof%2520and%2520application%2520as%2520medicaments%2520and%2520pharmaceutical%2520compositions%2520and%2520novel%2520use%2520as%2520MET%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span> </span><span class="NLM_article-title">Molecular property design: does everyone get it?</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=722-725&author=P.+D.+Leesonauthor=R.+J.+Young&title=Molecular+property+design%3A+does+everyone+get+it%3F&doi=10.1021%2Facsmedchemlett.5b00157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Property Design: Does Everyone Get It?</span></div><div class="casAuthors">Leeson, Paul D.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">722-725</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The principles of mol. property optimization in drug design have been understood for decades, yet much drug discovery activity today is conducted at the periphery of historical druglike property space.  Lead optimization trajectories aimed at reducing physicochem. risk, assisted by ligand efficiency metrics, could help to reduce clin. attrition rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_t8gIn79arVg90H21EOLACvtfcHk0lisyn5XL9Gbkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D&md5=5a807a8d049ce8cf4adc186891a9234d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00157%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMolecular%2520property%2520design%253A%2520does%2520everyone%2520get%2520it%253F%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D722%26epage%3D725%26doi%3D10.1021%2Facsmedchemlett.5b00157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lisyn5XL9Gbkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Doak, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobritzsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span> </span><span class="NLM_article-title">How beyond rule of 5 drugs and clinical candidates bind to their targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2327</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2312-2327&issue=6&author=B.+C.+Doakauthor=J.+Zhengauthor=D.+Dobritzschauthor=J.+Kihlberg&title=How+beyond+rule+of+5+drugs+and+clinical+candidates+bind+to+their+targets&doi=10.1021%2Facs.jmedchem.5b01286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets</span></div><div class="casAuthors">Doak, Bradley C.; Zheng, Jie; Dobritzsch, Doreen; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve discovery of drugs for difficult targets, the opportunities of chem. space beyond the rule of 5 (bRo5) were examd. by retrospective anal. of a comprehensive set of structures for complexes between drugs and clin. candidates and their targets.  The anal. illustrates the potential of compds. far beyond rule of 5 space to modulate novel and difficult target classes that have large, flat, and groove-shaped binding sites.  However, ligand efficiencies are significantly reduced for flat- and groove-shape binding sites, suggesting that adjustments of how to use such metrics are required.  Ligands bRo5 appear to benefit from an appropriate balance between rigidity and flexibility to bind with sufficient affinity to their targets, with macrocycles and nonmacrocycles being found to have similar flexibility.  However, macrocycles were more disk- and spherelike, which may contribute to their superior binding to flat sites, while rigidification of nonmacrocycles lead to rodlike ligands that bind well to groove-shaped binding sites.  These insights should contribute to altering perceptions of what targets are considered "druggable" and provide support for drug design in beyond rule of 5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZD-h9VodiPLVg90H21EOLACvtfcHk0lisyn5XL9Gbkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F&md5=a417b605d1a3ffbc7ee84706401f01f4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01286%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520beyond%2520rule%2520of%25205%2520drugs%2520and%2520clinical%2520candidates%2520bind%2520to%2520their%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2312%26epage%3D2327%26doi%3D10.1021%2Facs.jmedchem.5b01286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S.</span><span> </span><span class="NLM_article-title">Derivatives of 6-(6-O-cycloalkyl or 6-NH-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors</span>. WO2010089506 A1, Aug 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Bacque&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Derivatives+of+6-%286-O-cycloalkyl+or+6-NH-cycloalkyl-triazolopyridazine-sulfanyl%29+benzothiazoles+and+benzimidazoles%2C+preparation+thereof%2C+use+thereof+as+drugs%2C+and+use+thereof+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBacque%26aufirst%3DE.%26atitle%3DDerivatives%2520of%25206-%25286-O-cycloalkyl%2520or%25206-NH-cycloalkyl-triazolopyridazine-sulfanyl%2529%2520benzothiazoles%2520and%2520benzimidazoles%252C%2520preparation%2520thereof%252C%2520use%2520thereof%2520as%2520drugs%252C%2520and%2520use%2520thereof%2520as%2520MET%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nemecek, C.; Ugolini, A.; Wentzler, S.</span>. <span> </span><span class="NLM_article-title">Derivatives of 6-(6-O-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors</span>. WO2010089507 A1; Aug 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Derivatives+of+6-%286-O-substituted-triazolopyridazine-sulfanyl%29+benzothiazoles+and+benzimidazoles%2C+preparation+thereof%2C+use+thereof+as+drugs%2C+and+use+thereof+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNemecek%26aufirst%3DC.%26atitle%3DDerivatives%2520of%25206-%25286-O-substituted-triazolopyridazine-sulfanyl%2529%2520benzothiazoles%2520and%2520benzimidazoles%252C%2520preparation%2520thereof%252C%2520use%2520thereof%2520as%2520drugs%252C%2520and%2520use%2520thereof%2520as%2520MET%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span>. <span class="NLM_contrib-group">Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S.</span><span> </span><span class="NLM_article-title">Derivatives of 6-(6-NH-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as MET inhibitors</span>. WO2010089508 A1, Aug 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Sanofi-Aventis Fr.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Bacque&author=C.+Nemecek&author=A.+Ugolini&author=S.+Wentzler&title=Derivatives+of+6-%286-NH-substituted-triazolopyridazine-sulfanyl%29+benzothiazoles+and+benzimidazoles%2C+preparation+thereof%2C+use+thereof+as+drugs%2C+and+use+thereof+as+MET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBacque%26aufirst%3DE.%26atitle%3DDerivatives%2520of%25206-%25286-NH-substituted-triazolopyridazine-sulfanyl%2529%2520benzothiazoles%2520and%2520benzimidazoles%252C%2520preparation%2520thereof%252C%2520use%2520thereof%2520as%2520drugs%252C%2520and%2520use%2520thereof%2520as%2520MET%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Angevin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitaleri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollebecque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harnois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazuir, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assadourian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marinis, F.</span><span> </span><span class="NLM_article-title">A first-in-human (FIH) phase I study of SAR125844, a novel selective MET kinase inhibitor, in patients (pts) with advanced solid tumors: Dose escalation results</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">5 Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">2506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=2506&issue=5+Suppl.&author=E.+Angevinauthor=G.+Spitaleriauthor=A.+Hollebecqueauthor=T.+De+Pasauthor=J.+C.+Soriaauthor=M.+Harnoisauthor=F.+Mazuirauthor=S.+Assadourianauthor=F.+De+Marinis&title=A+first-in-human+%28FIH%29+phase+I+study+of+SAR125844%2C+a+novel+selective+MET+kinase+inhibitor%2C+in+patients+%28pts%29+with+advanced+solid+tumors%3A+Dose+escalation+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngevin%26aufirst%3DE.%26aulast%3DSpitaleri%26aufirst%3DG.%26aulast%3DHollebecque%26aufirst%3DA.%26aulast%3DDe%2BPas%26aufirst%3DT.%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26aulast%3DHarnois%26aufirst%3DM.%26aulast%3DMazuir%26aufirst%3DF.%26aulast%3DAssadourian%26aufirst%3DS.%26aulast%3DDe%2BMarinis%26aufirst%3DF.%26atitle%3DA%2520first-in-human%2520%2528FIH%2529%2520phase%2520I%2520study%2520of%2520SAR125844%252C%2520a%2520novel%2520selective%2520MET%2520kinase%2520inhibitor%252C%2520in%2520patients%2520%2528pts%2529%2520with%2520advanced%2520solid%2520tumors%253A%2520Dose%2520escalation%2520results%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26issue%3D5%2520Suppl%26spage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HLW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HLW','PDB','5HLW'); return false;">PDB: 5HLW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HNI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HNI','PDB','5HNI'); return false;">PDB: 5HNI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HO6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HO6','PDB','5HO6'); return false;">PDB: 5HO6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOA','PDB','5HOA'); return false;">PDB: 5HOA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOR','PDB','5HOR'); return false;">PDB: 5HOR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i4"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00280">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24250"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00280">10.1021/acs.jmedchem.6b00280</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis of SAR125844, overlay of structures, SMILES codes and data, and view of packing (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES codes and calculated molecular properties (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_001.pdf">jm6b00280_si_001.pdf (783.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00280/suppl_file/jm6b00280_si_002.csv">jm6b00280_si_002.csv (2.06 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited in the Protein Data Bank, <a href="http://www.pdb.org" class="extLink">www.pdb.org</a>, with the following PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HLW">5HLW</a> (compound <b>14</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HNI">5HNI</a> (compound <b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HO6">5HO6</a> (SAR125844-Y1230H), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOA">5HOA</a> (SAR125844-L1195V), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HOR">5HOR</a> (SAR125844-M1250T).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00280%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-15%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00280" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679931c0ebda3cc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
